14755679	Androgens	Taplin ME	Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.	Journal of cellular biochemistry	2004	96
15389811	Androgens	Miyamoto H	Androgen deprivation therapy for prostate cancer: current status and future prospects.	The Prostate	2004	77
19198621	Androgens	Harris WP	Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion.	Nature clinical practice. Urology	2009	142
20220849	Androgens	Ammirante M	B-cell-derived lymphotoxin promotes castration-resistant prostate cancer.	Nature	2010	148
20440270	Androgens	Niu Y	Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails.	Oncogene	2010	46
20577262	Androgens	Lian J	A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum.	Cell death and differentiation	2011	45
23806491	Androgens	Schrecengost R	Molecular pathogenesis and progression of prostate cancer.	Seminars in oncology	2013	26
23859952	Androgens	Shafi AA	Androgen receptors in hormone-dependent and castration-resistant prostate cancer.	Pharmacology & therapeutics	2013	53
27801901	Androgens	Benzon B	Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis.	Prostate cancer and prostatic diseases	2017	6
10334989	Estrogens	Fan S	BRCA1 inhibition of estrogen receptor signaling in transfected cells.	Science	1999	103
15181027	Estrogens	Bray GA	Medical consequences of obesity.	The Journal of clinical endocrinology and metabolism	2004	228
16012726	Estrogens	Tsutsui S	Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density.	Oncology reports	2005	92
17116942	Estrogens	Haffty BG	Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer.	Journal of clinical oncology 	2006	226
17910759	Estrogens	Kreike B	Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.	Breast cancer research 	2007	171
18413639	Estrogens	Nguyen PL	Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.	Journal of clinical oncology 	2008	162
18471979	Estrogens	Subramanian K	Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase.	Molecular cell	2008	92
19349544	Estrogens	Anderson SJ	Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.	Journal of clinical oncology 	2009	63
19720911	Estrogens	Millar EK	Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.	Journal of clinical oncology 	2009	69
20194857	Estrogens	Voduc KD	Breast cancer subtypes and the risk of local and regional relapse.	Journal of clinical oncology 	2010	247
21670451	Estrogens	Abdulkarim BS	Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.	Journal of clinical oncology 	2011	57
21747171	Estrogens	Tiano JP	Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes.	The Journal of clinical investigation	2011	50
21900114	Estrogens	Arvold ND	Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy.	Journal of clinical oncology 	2011	67
22503553	Estrogens	Klinge CM	miRNAs and estrogen action.	Trends in endocrinology and metabolism	2012	49
23045283	Estrogens	Chimge NO	The RUNX family in breast cancer: relationships with estrogen signaling.	Oncogene	2013	43
23425944	Estrogens	Ruddy KJ	Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship.	Annals of oncology 	2013	29
23436342	Estrogens	De Los Santos JF	Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.	Cancer	2013	27
23917289	Estrogens	Silber JH	Characteristics associated with differences in survival among black and white women with breast cancer.	JAMA	2013	68
24258260	Estrogens	Sørensen KP	Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer.	Breast cancer research and treatment	2013	66
24412361	Estrogens	Klein BJ	The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers.	Cell reports	2014	30
24469049	Estrogens	Cyr AR	TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.	Oncogene	2015	22
25488809	Estrogens	Wade MA	The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.	Nucleic acids research	2015	18
25529635	Estrogens	Glubb DM	Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.	American journal of human genetics	2015	23
25979954	Estrogens	Guttery DS	Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancer.	Clinical chemistry	2015	27
26341644	Estrogens	Kumar P	An overview of triple-negative breast cancer.	Archives of gynecology and obstetrics	2016	19
26909695	Estrogens	Rostami R	Brain metastasis in breast cancer: a comprehensive literature review.	Journal of neuro-oncology	2016	13
26928228	Estrogens	Dunning AM	Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.	Nature genetics	2016	18
26960396	Estrogens	Piscuoglio S	The Genomic Landscape of Male Breast Cancers.	Clinical cancer research 	2016	16
26987290	Estrogens	Sun X	Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells.	Cancer gene therapy	2016	10
27225691	Estrogens	Speers C	Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer.	Clinical cancer research 	2016	13
27748765	Estrogens	Harrod A	Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.	Oncogene	2017	8
27940449	Estrogens	Page K	Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer.	Clinical chemistry	2017	6
28030809	Estrogens	McDaniel JM	Genomic regulation of invasion by STAT3 in triple negative breast cancer.	Oncotarget	2017	6
3317417	Insulin	Cooper GJ	Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.	Proceedings of the National Academy of Sciences of the United States of America	1987	182
10953019	Insulin	Ginsberg HN	Insulin resistance and cardiovascular disease.	The Journal of clinical investigation	2000	154
11686294	Insulin	Lawlor MA	PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?	Journal of cell science	2001	231
11694656	Insulin	Giovannucci E	Insulin, insulin-like growth factors and colon cancer: a review of the evidence.	The Journal of nutrition	2001	211
15192089	Insulin	Meng TC	Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B.	The Journal of biological chemistry	2004	75
15383514	Insulin	Esposito K	Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial.	JAMA	2004	298
15546863	Insulin	Viniegra JG	Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM.	The Journal of biological chemistry	2005	79
16036612	Insulin	Karin M	From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.	IUBMB life	2005	124
16426829	Insulin	Gunter MJ	Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes.	The Journal of nutritional biochemistry	2006	69
16531507	Insulin	Yang RZ	Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action.	American journal of physiology. Endocrinology and metabolism	2006	108
16627931	Insulin	Lester-Coll N	Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.	Journal of Alzheimer's disease 	2006	109
17132539	Insulin	Sugden MC	Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases.	Archives of physiology and biochemistry	2006	65
19188682	Insulin	Qatanani M	Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.	The Journal of clinical investigation	2009	51
19207680	Insulin	Ricchi M	Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.	Journal of gastroenterology and hepatology	2009	83
21441594	Insulin	Taylor RC	Aging as an event of proteostasis collapse.	Cold Spring Harbor perspectives in biology	2011	125
22307032	Insulin	Liu J	Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice.	Gastroenterology	2012	45
23652116	Insulin	Ahmadian M	PPARγ signaling and metabolism: the good, the bad and the future.	Nature medicine	2013	284
23932846	Insulin	Aroor AR	Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.	Metabolism	2013	47
24613355	Insulin	Chen YJ	De novo formation of insulin-producing "neo-β cell islets" from intestinal crypts.	Cell reports	2014	33
27376324	Insulin	Yoon MS	The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism.	Nutrients	2016	16
27565734	Insulin	Sawada T	Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.	Cardiovascular diabetology	2016	10
8128219	Phosphates	Barford D	Crystal structure of human protein tyrosine phosphatase 1B.	Science	1994	132
12952917	Phosphates	Riminucci M	FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.	The Journal of clinical investigation	2003	134
15579309	Phosphates	Sitara D	Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.	Matrix biology 	2004	128
16037577	Phosphates	Hruska KA	Bone morphogenetic proteins in vascular calcification.	Circulation research	2005	82
16358214	Phosphates	Bergwitz C	SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis.	American journal of human genetics	2006	84
17033625	Phosphates	Lorenz-Depiereux B	DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis.	Nature genetics	2006	151
17470781	Phosphates	Tsai CJ	Cernunnos/XLF promotes the ligation of mismatched and noncohesive DNA ends.	Proceedings of the National Academy of Sciences of the United States of America	2007	71
18037646	Phosphates	Qin C	Dentin matrix protein 1 (DMP1): new and important roles for biomineralization and phosphate homeostasis.	Journal of dental research	2007	57
18179800	Phosphates	Li X	BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells.	Atherosclerosis	2008	66
18687639	Phosphates	Gutiérrez OM	Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.	The New England journal of medicine	2008	398
20392236	Phosphates	Whyte MP	Physiological role of alkaline phosphatase explored in hypophosphatasia.	Annals of the New York Academy of Sciences	2010	43
20593414	Phosphates	Jüppner H	FGF-23: More than a regulator of renal phosphate handling?	Journal of bone and mineral research 	2010	45
21115613	Phosphates	Hu MC	Klotho deficiency causes vascular calcification in chronic kidney disease.	Journal of the American Society of Nephrology 	2011	197
21454719	Phosphates	Cunningham J	Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.	Clinical journal of the American Society of Nephrology 	2011	58
21490240	Phosphates	Chong WH	Tumor-induced osteomalacia.	Endocrine-related cancer	2011	64
22421513	Phosphates	Quarles LD	Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.	Experimental cell research	2012	48
22622492	Phosphates	Wolf M	Update on fibroblast growth factor 23 in chronic kidney disease.	Kidney international	2012	68
23389416	Phosphates	Scialla JJ	Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.	Kidney international	2013	61
23774819	Phosphates	Kuro-o M	Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism.	Nature reviews. Nephrology	2013	31
24466013	Phosphates	Sakan H	Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism.	PloS one	2014	31
24686452	Phosphates	Scialla JJ	Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.	Nature reviews. Nephrology	2014	30
24695641	Phosphates	Six I	Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium.	PloS one	2014	21
24920722	Phosphates	Mathew JS	Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).	Circulation	2014	22
25195011	Phosphates	Chaikuad A	A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics.	Nature chemical biology	2014	31
25695404	Phosphates	Xu Y	Molecular basis of Klotho: from gene to function in aging.	Endocrine reviews	2015	28
25916871	Phosphates	Schlieper G	Vascular calcification in chronic kidney disease: an update.	Nephrology, dialysis, transplantation 	2016	11
25967123	Phosphates	Isakova T	Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.	Journal of the American Society of Nephrology 	2015	25
8446617	Peptides	Strittmatter WJ	Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.	Proceedings of the National Academy of Sciences of the United States of America	1993	664
9560253	Peptides	Lee N	HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.	Proceedings of the National Academy of Sciences of the United States of America	1998	156
11386265	Peptides	Gao X	Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.	The New England journal of medicine	2001	144
12093752	Peptides	Ustrell V	PA200, a nuclear proteasome activator involved in DNA repair.	The EMBO journal	2002	81
12631714	Peptides	Markosyan RM	HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation.	Molecular biology of the cell	2003	87
14977407	Peptides	Daniel H	Molecular and integrative physiology of intestinal peptide transport.	Annual review of physiology	2004	71
15117938	Peptides	Brewer BY	RNA sequence elements required for high affinity binding by the zinc finger domain of tristetraprolin: conformational changes coupled to the bipartite nature of Au-rich MRNA-destabilizing motifs.	The Journal of biological chemistry	2004	74
20356827	Peptides	Dai S	Crystal structure of HLA-DP2 and implications for chronic beryllium disease.	Proceedings of the National Academy of Sciences of the United States of America	2010	42
20516121	Peptides	Nam JM	Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin.	Cancer research	2010	53
20595511	Peptides	Wild D	Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.	Journal of nuclear medicine 	2010	44
21297667	Peptides	Switzer CH	Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy.	Oncogene	2011	42
21349845	Peptides	Gerken TA	Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases.	The Journal of biological chemistry	2011	35
21550982	Peptides	Zhou X	Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs.	The Journal of biological chemistry	2011	48
22622039	Peptides	LaBelle JL	A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers.	The Journal of clinical investigation	2012	62
23150796	Peptides	Yan H	Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.	eLife	2012	288
23995836	Peptides	Rauh D	An acetylome peptide microarray reveals specificities and deacetylation substrates for all human sirtuin isoforms.	Nature communications	2013	29
25624485	Peptides	Leshchiner ES	Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices.	Proceedings of the National Academy of Sciences of the United States of America	2015	24
26523866	Peptides	Adams JJ	Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity.	Nature immunology	2016	27
10484602	Fatty Acids, Unsaturated	Ntambi JM	Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol.	Journal of lipid research	1999	101
11395411	Fatty Acids, Unsaturated	Willson TM	Peroxisome proliferator-activated receptor gamma and metabolic disease.	Annual review of biochemistry	2001	114
11744348	Fatty Acids, Unsaturated	Das UN	Is obesity an inflammatory condition?	Nutrition	2001	128
12583947	Fatty Acids, Unsaturated	Thies F	Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial.	Lancet	2003	106
12821543	Fatty Acids, Unsaturated	Pischon T	Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women.	Circulation	2003	97
15189125	Fatty Acids, Unsaturated	Nakamura MT	Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases.	Annual review of nutrition	2004	150
15555528	Fatty Acids, Unsaturated	SanGiovanni JP	The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina.	Progress in retinal and eye research	2005	126
17942962	Fatty Acids, Unsaturated	Yamamoto T	Renal L-type fatty acid--binding protein in acute ischemic injury.	Journal of the American Society of Nephrology 	2007	61
18320251	Fatty Acids, Unsaturated	Malerba G	SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease.	Lipids	2008	70
18504706	Fatty Acids, Unsaturated	Calder PC	Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases.	Molecular nutrition & food research	2008	67
18573585	Fatty Acids, Unsaturated	Chiu CC	The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.	Progress in neuro-psychopharmacology & biological psychiatry	2008	68
18728184	Fatty Acids, Unsaturated	Agbaga MP	Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids.	Proceedings of the National Academy of Sciences of the United States of America	2008	70
19148276	Fatty Acids, Unsaturated	Tanaka T	Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study.	PLoS genetics	2009	130
19594757	Fatty Acids, Unsaturated	Kohli P	Resolvins and protectins: mediating solutions to inflammation.	British journal of pharmacology	2009	59
25124495	Fatty Acids, Unsaturated	Wu JH	Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study.	Circulation	2014	25
25387473	Fatty Acids, Unsaturated	Bazinet RP	Polyunsaturated fatty acids and their metabolites in brain function and disease.	Nature reviews. Neuroscience	2014	99
25498862	Fatty Acids, Unsaturated	Liu JJ	Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.	Brain research	2015	16
25581263	Fatty Acids, Unsaturated	Arendt BM	Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids.	Hepatology	2015	16
25586377	Fatty Acids, Unsaturated	Niso-Santano M	Unsaturated fatty acids induce non-canonical autophagy.	The EMBO journal	2015	17
25911511	Fatty Acids, Unsaturated	Cenac N	Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.	Gastroenterology	2015	15
26005184	Fatty Acids, Unsaturated	Khan MZ	The role of polyunsaturated fatty acids and GPR40 receptor in brain.	Neuropharmacology	2017	7
27789233	Fatty Acids, Unsaturated	Tsikas D	Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges.	Analytical biochemistry	2017	9
27893018	Fatty Acids, Unsaturated	McGorry PD	Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.	JAMA psychiatry	2017	10
28207502	Fatty Acids, Unsaturated	Mazidi M	Impact of the dietary fatty acid intake on C-reactive protein levels in US adults.	Medicine	2017	7
28359749	Fatty Acids, Unsaturated	Andrieu S	Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.	The Lancet. Neurology	2017	12
12569601	Glucose	Kunkel M	Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.	Cancer	2003	78
15747110	Glucose	Bugianesi E	Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.	Diabetologia	2005	117
17498512	Glucose	Parekh S	Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.	Gastroenterology	2007	76
17499247	Glucose	Calderwood SK	Extracellular heat shock proteins in cell signaling.	FEBS letters	2007	87
17551816	Glucose	Semenza GL	HIF-1 mediates the Warburg effect in clear cell renal carcinoma.	Journal of bioenergetics and biomembranes	2007	80
17889646	Glucose	Dai C	Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.	Cell	2007	300
19143055	Glucose	Denko NC	Hypoxia, HIF1 and glucose metabolism in the solid tumour.	Nature reviews. Cancer	2008	331
19357407	Glucose	Virtanen KA	Functional brown adipose tissue in healthy adults.	The New England journal of medicine	2009	722
19357959	Glucose	Jensen RL	Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.	Journal of neuro-oncology	2009	81
19501581	Glucose	Meshkani R	Hepatic insulin resistance, metabolic syndrome and cardiovascular disease.	Clinical biochemistry	2009	68
19706948	Glucose	Roa W	Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle.	Nanotechnology	2009	50
20018949	Glucose	Santi SA	The Akt isoforms are present at distinct subcellular locations.	American journal of physiology. Cell physiology	2010	49
20206201	Glucose	Ralph SJ	The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.	Molecular aspects of medicine	2010	87
20473272	Glucose	Ye J	The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation.	The EMBO journal	2010	146
20935668	Glucose	Cannon B	Metabolic consequences of the presence or absence of the thermogenic capacity of brown adipose tissue in mice (and probably in humans).	International journal of obesity	2010	54
21375707	Glucose	Nedergaard J	Three years with adult human brown adipose tissue.	Annals of the New York Academy of Sciences	2010	51
21456517	Glucose	Lorenz MA	Reducing time and increasing sensitivity in sample preparation for adherent mammalian cell metabolomics.	Analytical chemistry	2011	52
21803297	Glucose	Orava J	Different metabolic responses of human brown adipose tissue to activation by cold and insulin.	Cell metabolism	2011	154
21960526	Glucose	Dang CV	Therapeutic targeting of Myc-reprogrammed cancer cell metabolism.	Cold Spring Harbor symposia on quantitative biology	2011	45
22017876	Glucose	Zhao Y	DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(βTrCP) E3 ubiquitin ligase and regulates survival and autophagy.	Molecular cell	2011	81
22553379	Glucose	Stancáková A	Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men.	Diabetes	2012	60
23071360	Glucose	Meijer TW	Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy.	Clinical cancer research 	2012	80
23075985	Glucose	Sun L	Crystal structure of a bacterial homologue of glucose transporters GLUT1-4.	Nature	2012	111
23143398	Glucose	Trajkovski M	MyomiR-133 regulates brown fat differentiation through Prdm16.	Nature cell biology	2012	65
23431266	Glucose	Girousse A	Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass.	PLoS biology	2013	41
23440242	Glucose	Ambrose M	Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions.	Blood	2013	39
23603815	Glucose	Cypess AM	Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat.	Nature medicine	2013	170
23657158	Glucose	Ruiz-Núñez B	Lifestyle and nutritional imbalances associated with Western diseases: causes and consequences of chronic systemic low-grade inflammation in an evolutionary context.	The Journal of nutritional biochemistry	2013	26
23859617	Glucose	Guo D	Targeting SREBP-1-driven lipid metabolism to treat cancer.	Current pharmaceutical design	2014	35
23906881	Glucose	Dang CV	MYC, metabolism, cell growth, and tumorigenesis.	Cold Spring Harbor perspectives in medicine	2013	140
23988176	Glucose	Semenza GL	Hypoxia-inducible factor 1 and cardiovascular disease.	Annual review of physiology	2014	71
24018562	Glucose	Hodson DJ	Lipotoxicity disrupts incretin-regulated human β cell connectivity.	The Journal of clinical investigation	2013	53
24037093	Glucose	Taniguchi CM	Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.	Nature medicine	2013	33
24315620	Glucose	Kahn SE	Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.	Lancet	2014	141
24384568	Glucose	Boucher J	Insulin receptor signaling in normal and insulin-resistant states.	Cold Spring Harbor perspectives in biology	2014	78
24388967	Glucose	Bryant KL	KRAS: feeding pancreatic cancer proliferation.	Trends in biochemical sciences	2014	99
24662831	Glucose	Xiao L	Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.	Oncogene	2014	30
24954193	Glucose	Lee P	Temperature-acclimated brown adipose tissue modulates insulin sensitivity in humans.	Diabetes	2014	60
25056438	Glucose	Chondronikola M	Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans.	Diabetes	2014	114
25119025	Glucose	Faehnle CR	Mechanism of Dis3l2 substrate recognition in the Lin28-let-7 pathway.	Nature	2014	31
25149919	Glucose	Pfeifer A	Brown, beige, and white: the new color code of fat and its pharmacological implications.	Annual review of pharmacology and toxicology	2015	21
25421524	Glucose	Thorens B	GLUT2, glucose sensing and glucose homeostasis.	Diabetologia	2015	42
25668019	Glucose	Valdearcos M	Hypothalamic inflammation in the control of metabolic function.	Annual review of physiology	2015	25
25688211	Glucose	Poher AL	Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance.	Frontiers in physiology	2015	35
25751139	Glucose	Wang W	AMPK modulates Hippo pathway activity to regulate energy homeostasis.	Nature cell biology	2015	73
25957687	Glucose	Aït-Ali N	Rod-derived cone viability factor promotes cone survival by stimulating aerobic glycolysis.	Cell	2015	39
26147760	Glucose	Hanssen MJ	Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus.	Nature medicine	2015	48
26192967	Glucose	Toulany M	Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.	Seminars in cancer biology	2015	19
26718499	Glucose	Hanssen MJ	Short-term Cold Acclimation Recruits Brown Adipose Tissue in Obese Humans.	Diabetes	2016	20
26912151	Glucose	Kim SH	Brown Fat and Browning for the Treatment of Obesity and Related Metabolic Disorders.	Diabetes & metabolism journal	2016	20
27034277	Glucose	Riehle C	Insulin Signaling and Heart Failure.	Circulation research	2016	19
27557514	Glucose	Zou ZW	LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells.	Oncotarget	2016	17
27982707	Glucose	Kovatchev B	Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.	Diabetes technology & therapeutics	2017	10
28199306	Glucose	Wolfson RL	KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1.	Nature	2017	19
11992116	Ethanol	Trevisani M	Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1.	Nature neuroscience	2002	88
15670660	Ethanol	Lieber CS	Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.	Alcohol	2004	141
15830281	Ethanol	Llovet JM	Updated treatment approach to hepatocellular carcinoma.	Journal of gastroenterology	2005	129
16488803	Ethanol	Fentiman IS	Male breast cancer.	Lancet	2006	88
19296670	Ethanol	Kollman JM	Crystal structure of human fibrinogen.	Biochemistry	2009	59
20451455	Ethanol	Marur S	HPV-associated head and neck cancer: a virus-related cancer epidemic.	The Lancet. Oncology	2010	313
22308024	Ethanol	Yin H	MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1.	The Journal of biological chemistry	2012	43
26005677	Ethanol	Basaranoglu M	Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction.	Hepatobiliary surgery and nutrition	2015	20
7545954	Zinc	Miki Y	A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.	Science	1994	880
9486654	Zinc	Lin RJ	Role of the histone deacetylase complex in acute promyelocytic leukaemia.	Nature	1998	210
10375510	Zinc	Ruiz i Altaba A	Gli proteins encode context-dependent positive and negative functions: implications for development and disease.	Development	1999	104
10783169	Zinc	Zhao R	Analysis of p53-regulated gene expression patterns using oligonucleotide arrays.	Genes & development	2000	166
12798299	Zinc	Moss EG	Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites.	Developmental biology	2003	102
16971064	Zinc	Guo Y	Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma.	Gene	2006	104
17110336	Zinc	Le Cam L	E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation.	Cell	2006	67
17116689	Zinc	Lindström MS	Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.	Molecular and cellular biology	2007	63
18385818	Zinc	Prasad AS	Zinc in human health: effect of zinc on immune cells.	Molecular medicine	2008	68
19710611	Zinc	Prasad AS	Zinc: role in immunity, oxidative stress and chronic inflammation.	Current opinion in clinical nutrition and metabolic care	2009	66
20579626	Zinc	Lapunzina P	Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta.	American journal of human genetics	2010	57
20818382	Zinc	Berg IL	PRDM9 variation strongly influences recombination hot-spot activity and meiotic instability in humans.	Nature genetics	2010	130
22266823	Zinc	Kim H	Regulation of Rev1 by the Fanconi anemia core complex.	Nature structural & molecular biology	2012	73
22396592	Zinc	Leung JW	Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair.	Proceedings of the National Academy of Sciences of the United States of America	2012	41
22829947	Zinc	Chen H	Comprehensive identification and annotation of cell type-specific and ubiquitous CTCF-binding sites in the human genome.	PloS one	2012	42
25086746	Zinc	Zhang P	ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.	Nature cell biology	2014	56
25476932	Zinc	Zhang P	miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.	Nature communications	2014	29
25607528	Zinc	Zhang P	ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance.	Cell cycle	2015	65
26527725	Zinc	Wang J	Highly efficient homology-driven genome editing in human T cells by combining zinc-finger nuclease mRNA and AAV6 donor delivery.	Nucleic acids research	2016	17
26645689	Zinc	Horton JR	Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.	The Journal of biological chemistry	2016	10
8093612	Adenosine Triphosphate	Jakob U	Small heat shock proteins are molecular chaperones.	The Journal of biological chemistry	1993	247
9500542	Adenosine Triphosphate	Bull LN	A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis.	Nature genetics	1998	117
10395545	Adenosine Triphosphate	Riballo E	Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient.	Current biology 	1999	96
10620491	Adenosine Triphosphate	Ricquier D	The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP.	The Biochemical journal	2000	112
10934467	Adenosine Triphosphate	Saleh A	Negative regulation of the Apaf-1 apoptosome by Hsp70.	Nature cell biology	2000	147
12429862	Adenosine Triphosphate	Jonker JW	The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.	Proceedings of the National Academy of Sciences of the United States of America	2002	127
12717402	Adenosine Triphosphate	Neuschwander-Tetri BA	Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.	Hepatology	2003	371
14624239	Adenosine Triphosphate	Ellison V	Biochemical characterization of DNA damage checkpoint complexes: clamp loader and clamp complexes with specificity for 5' recessed DNA.	PLoS biology	2003	134
14709597	Adenosine Triphosphate	Cideciyan AV	Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence.	Human molecular genetics	2004	78
15099516	Adenosine Triphosphate	Nagaich AK	Rapid periodic binding and displacement of the glucocorticoid receptor during chromatin remodeling.	Molecular cell	2004	75
15740751	Adenosine Triphosphate	DeLaBarre B	Nucleotide dependent motion and mechanism of action of p97/VCP.	Journal of molecular biology	2005	73
15800637	Adenosine Triphosphate	Rivas FV	Purified Argonaute2 and an siRNA form recombinant human RISC.	Nature structural & molecular biology	2005	234
15888659	Adenosine Triphosphate	Liu B	Functional recovery from desensitization of vanilloid receptor TRPV1 requires resynthesis of phosphatidylinositol 4,5-bisphosphate.	The Journal of neuroscience 	2005	73
16098463	Adenosine Triphosphate	Moeller BJ	Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.	Cancer cell	2005	111
16543131	Adenosine Triphosphate	Ishibashi T	Astrocytes promote myelination in response to electrical impulses.	Neuron	2006	179
17114456	Adenosine Triphosphate	Mambula SS	Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes.	Journal of immunology	2006	97
17322922	Adenosine Triphosphate	Lou H	Targeted therapy for cancer stem cells: the patched pathway and ABC transporters.	Oncogene	2007	62
17353904	Adenosine Triphosphate	Sims-Mourtada J	Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport.	Oncogene	2007	76
17573453	Adenosine Triphosphate	Ryan JL	Mechanisms of cancer-related fatigue.	The oncologist	2007	88
17728465	Adenosine Triphosphate	Matute C	P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis.	The Journal of neuroscience 	2007	80
19047635	Adenosine Triphosphate	Anselmi F	ATP release through connexin hemichannels and gap junction transfer of second messengers propagate Ca2+ signals across the inner ear.	Proceedings of the National Academy of Sciences of the United States of America	2008	109
19060884	Adenosine Triphosphate	van Mameren J	Counting RAD51 proteins disassembling from nucleoprotein filaments under tension.	Nature	2009	71
19118027	Adenosine Triphosphate	Banerji U	Heat shock protein 90 as a drug target: some like it hot.	Clinical cancer research 	2009	73
19246570	Adenosine Triphosphate	Huttenhower C	Exploring the human genome with functional maps.	Genome research	2009	97
19272168	Adenosine Triphosphate	Gao X	Molecular mechanisms of cell proliferation induced by low power laser irradiation.	Journal of biomedical science	2009	54
19669158	Adenosine Triphosphate	Mandadi S	TRPV3 in keratinocytes transmits temperature information to sensory neurons via ATP.	Pflugers Archiv 	2009	70
19753307	Adenosine Triphosphate	Chen Y	Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect.	PloS one	2009	55
19805629	Adenosine Triphosphate	Lamkanfi M	Glyburide inhibits the Cryopyrin/Nalp3 inflammasome.	The Journal of cell biology	2009	176
19892975	Adenosine Triphosphate	Cartier N	Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.	Science	2009	382
20805324	Adenosine Triphosphate	Larsen DH	The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage.	The Journal of cell biology	2010	88
21172662	Adenosine Triphosphate	Lan L	The ACF1 complex is required for DNA double-strand break repair in human cells.	Molecular cell	2010	74
21196229	Adenosine Triphosphate	Richard D	Brown fat biology and thermogenesis.	Frontiers in bioscience	2011	60
21813754	Adenosine Triphosphate	Chan DA	Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality.	Science translational medicine	2011	92
21900605	Adenosine Triphosphate	Vlashi E	Metabolic state of glioma stem cells and nontumorigenic cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	113
22110477	Adenosine Triphosphate	Ma ZA	Mitochondrial dysfunction and β-cell failure in type 2 diabetes mellitus.	Experimental diabetes research	2012	43
22492724	Adenosine Triphosphate	Luijsterburg MS	DDB2 promotes chromatin decondensation at UV-induced DNA damage.	The Journal of cell biology	2012	51
22608503	Adenosine Triphosphate	van Bon BW	Cantú syndrome is caused by mutations in ABCC9.	American journal of human genetics	2012	34
22705370	Adenosine Triphosphate	Yuan J	The HARP-like domain-containing protein AH2/ZRANB3 binds to PCNA and participates in cellular response to replication stress.	Molecular cell	2012	32
22784115	Adenosine Triphosphate	Srivastava R	Potassium channel KIR4.1 as an immune target in multiple sclerosis.	The New England journal of medicine	2012	80
22833457	Adenosine Triphosphate	Elo JM	Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy.	Human molecular genetics	2012	42
22902320	Adenosine Triphosphate	Dorn GW 2nd	SR and mitochondria: calcium cross-talk between kissing cousins.	Journal of molecular and cellular cardiology	2013	27
23134727	Adenosine Triphosphate	Bouazoune K	Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disorders.	Proceedings of the National Academy of Sciences of the United States of America	2012	34
23394946	Adenosine Triphosphate	Cang C	mTOR regulates lysosomal ATP-sensitive two-pore Na(+) channels to adapt to metabolic state.	Cell	2013	84
23415156	Adenosine Triphosphate	Tarling EJ	Role of ABC transporters in lipid transport and human disease.	Trends in endocrinology and metabolism	2013	49
23483818	Adenosine Triphosphate	Basaranoglu M	From fatty liver to fibrosis: a tale of "second hit".	World journal of gastroenterology	2013	39
23685672	Adenosine Triphosphate	Lavoie H	Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization.	Nature chemical biology	2013	26
23886445	Adenosine Triphosphate	Tao R	Regulation of MnSOD enzymatic activity by Sirt3 connects the mitochondrial acetylome signaling networks to aging and carcinogenesis.	Antioxidants & redox signaling	2014	34
24037090	Adenosine Triphosphate	Ko A	Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling.	Cell death and differentiation	2014	54
24142455	Adenosine Triphosphate	Pollak KA	Exogenously applied muscle metabolites synergistically evoke sensations of muscle fatigue and pain in human subjects.	Experimental physiology	2014	37
24462205	Adenosine Triphosphate	Mollapour M	Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors.	Molecular cell	2014	31
24480782	Adenosine Triphosphate	Gameiro SR	Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing.	Oncotarget	2014	68
24568233	Adenosine Triphosphate	Naeser MA	Significant improvements in cognitive performance post-transcranial, red/near-infrared light-emitting diode treatments in chronic, mild traumatic brain injury: open-protocol study.	Journal of neurotrauma	2014	31
24746669	Adenosine Triphosphate	Wang Z	Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression.	Developmental cell	2014	37
24768297	Adenosine Triphosphate	Liang H	PTENα, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism.	Cell metabolism	2014	45
25091424	Adenosine Triphosphate	Desbats MA	Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency.	Journal of inherited metabolic disease	2015	26
25119037	Adenosine Triphosphate	Van Nostrand JL	Inappropriate p53 activation during development induces features of CHARGE syndrome.	Nature	2014	33
25482473	Adenosine Triphosphate	Parihar P	Mitochondrial sirtuins: emerging roles in metabolic regulations, energy homeostasis and diseases.	Experimental gerontology	2015	16
25775548	Adenosine Triphosphate	Zhang X	Altered cofactor regulation with disease-associated p97/VCP mutations.	Proceedings of the National Academy of Sciences of the United States of America	2015	22
25807077	Adenosine Triphosphate	Lu CL	Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.	PloS one	2015	23
25890351	Adenosine Triphosphate	Yang Z	T-cell metabolism in autoimmune disease.	Arthritis research & therapy	2015	22
25941621	Adenosine Triphosphate	Kepp O	Consensus guidelines for the detection of immunogenic cell death.	Oncoimmunology	2014	114
26378229	Adenosine Triphosphate	Stransky LA	Amino Acid Availability Modulates Vacuolar H+-ATPase Assembly.	The Journal of biological chemistry	2015	23
26698230	Adenosine Triphosphate	Nitulescu GM	Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review).	International journal of oncology	2016	27
27117941	Adenosine Triphosphate	Kleszczyński K	Melatonin enhances mitochondrial ATP synthesis, reduces reactive oxygen species formation, and mediates translocation of the nuclear erythroid 2-related factor 2 resulting in activation of phase-2 antioxidant enzymes (γ-GCS, HO-1, NQO1) in ultraviolet radiation-treated normal human epidermal keratinocytes (NHEK).	Journal of pineal research	2016	12
27335445	Adenosine Triphosphate	Stransky L	The Function of V-ATPases in Cancer.	Physiological reviews	2016	12
27350397	Adenosine Triphosphate	Daulatzai MA	Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.	Journal of neuroscience research	2017	14
27413115	Adenosine Triphosphate	Hodges C	The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer.	Cold Spring Harbor perspectives in medicine	2016	16
28060726	Adenosine Triphosphate	Ogawa M	Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity.	Oncotarget	2017	11
28112645	Adenosine Triphosphate	Tocilj A	Structure of the active form of human origin recognition complex and its ATPase motor module.	eLife	2017	6
28360422	Adenosine Triphosphate	Weyand CM	Immunometabolism in early and late stages of rheumatoid arthritis.	Nature reviews. Rheumatology	2017	6
7620916	Cysteine	Zimmer DB	The S100 protein family: history, function, and expression.	Brain research bulletin	1995	126
11353823	Cysteine	Ghanouni P	Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor.	Proceedings of the National Academy of Sciences of the United States of America	2001	86
12855764	Cysteine	Wilson MA	The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2003	91
14988435	Cysteine	Wu G	Glutathione metabolism and its implications for health.	The Journal of nutrition	2004	361
15081400	Cysteine	Kinumi T	Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells.	Biochemical and biophysical research communications	2004	93
15094120	Cysteine	Bellail AC	Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion.	The international journal of biochemistry & cell biology	2004	124
16046058	Cysteine	Liaudet-Coopman E	Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis.	Cancer letters	2006	73
17084981	Cysteine	Hehlgans S	Signalling via integrins: implications for cell survival and anticancer strategies.	Biochimica et biophysica acta	2007	105
17673662	Cysteine	Johnson CP	Forced unfolding of proteins within cells.	Science	2007	130
18251510	Cysteine	Rachakonda G	Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3.	Chemical research in toxicology	2008	55
19124468	Cysteine	Blackinton J	Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1.	The Journal of biological chemistry	2009	80
19567589	Cysteine	Lucio-Eterovic AK	Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.	Clinical cancer research 	2009	75
20194792	Cysteine	Zhou Y	Pore architecture of the ORAI1 store-operated calcium channel.	Proceedings of the National Academy of Sciences of the United States of America	2010	61
21406728	Cysteine	Miliani de Marval PL	The RP-Mdm2-p53 pathway and tumorigenesis.	Oncotarget	2011	40
22535894	Cysteine	Frangogiannis NG	Matricellular proteins in cardiac adaptation and disease.	Physiological reviews	2012	114
22573178	Cysteine	Budke B	RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells.	Nucleic acids research	2012	50
23001121	Cysteine	Nilius B	The transient receptor potential channel TRPA1: from gene to pathophysiology.	Pflugers Archiv 	2012	74
24491257	Cysteine	Kimura H	The physiological role of hydrogen sulfide and beyond.	Nitric oxide 	2014	34
24675529	Cysteine	Nagaraju GP	Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis.	Carcinogenesis	2014	26
25460271	Cysteine	Malinauskas T	Extracellular modulators of Wnt signalling.	Current opinion in structural biology	2014	21
25929483	Cysteine	Yin J	L-Cysteine metabolism and its nutritional implications.	Molecular nutrition & food research	2016	10
27027295	Cysteine	Chouchani ET	Mitochondrial ROS regulate thermogenic energy expenditure and sulfenylation of UCP1.	Nature	2016	36
9425501	Parathyroid Hormone	Chapuy MC	Prevalence of vitamin D insufficiency in an adult normal population.	Osteoporosis international 	1997	190
14671166	Parathyroid Hormone	Visser M	Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam.	The Journal of clinical endocrinology and metabolism	2003	128
18375760	Parathyroid Hormone	Pioszak AA	Molecular recognition of parathyroid hormone by its G protein-coupled receptor.	Proceedings of the National Academy of Sciences of the United States of America	2008	96
18667733	Parathyroid Hormone	Regidor DL	Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.	Journal of the American Society of Nephrology 	2008	58
19451355	Parathyroid Hormone	Hagström E	Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.	Circulation	2009	86
20431993	Parathyroid Hormone	Ardawi MS	Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women.	Osteoporosis international 	2011	45
20614473	Parathyroid Hormone	Kalantar-Zadeh K	Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients.	Journal of bone and mineral research 	2010	46
21389978	Parathyroid Hormone	Isakova T	Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.	Kidney international	2011	225
21436289	Parathyroid Hormone	Wolf M	Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.	Journal of the American Society of Nephrology 	2011	70
21608424	Parathyroid Hormone	Hovsepian S	Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran.	Journal of health, population, and nutrition	2011	41
23129826	Parathyroid Hormone	Pavik I	Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.	Nephrology, dialysis, transplantation 	2013	36
23243213	Parathyroid Hormone	Scialla JJ	Mineral metabolites and CKD progression in African Americans.	Journal of the American Society of Nephrology 	2013	31
23652549	Parathyroid Hormone	Hu MC	Klotho and chronic kidney disease.	Contributions to nephrology	2013	28
26321176	Parathyroid Hormone	Sprague SM	Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.	American journal of kidney diseases 	2016	13
9806540	Bile Acids and Salts	Strautnieks SS	A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis.	Nature genetics	1998	142
12093894	Bile Acids and Salts	Pullinger CR	Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype.	The Journal of clinical investigation	2002	82
12663868	Bile Acids and Salts	Trauner M	Bile salt transporters: molecular characterization, function, and regulation.	Physiological reviews	2003	165
14699511	Bile Acids and Salts	Kullak-Ublick GA	Enterohepatic bile salt transporters in normal physiology and liver disease.	Gastroenterology	2004	88
17404808	Bile Acids and Salts	Alrefai WA	Bile acid transporters: structure, function, regulation and pathophysiological implications.	Pharmaceutical research	2007	68
20730630	Bile Acids and Salts	Itoh N	Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.	Cell and tissue research	2010	47
21103971	Bile Acids and Salts	Stieger B	The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.	Handbook of experimental pharmacology	2011	44
21976025	Bile Acids and Salts	Hu NJ	Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT.	Nature	2011	53
22111624	Bile Acids and Salts	Lorbek G	Cytochrome P450s in the synthesis of cholesterol and bile acids--from mouse models to human diseases.	The FEBS journal	2012	35
22403795	Bile Acids and Salts	Camilleri M	Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.	American journal of physiology. Gastrointestinal and liver physiology	2012	34
22414897	Bile Acids and Salts	Calkin AC	Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.	Nature reviews. Molecular cell biology	2012	149
22550135	Bile Acids and Salts	Porez G	Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease.	Journal of lipid research	2012	47
22652341	Bile Acids and Salts	Adorini L	Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis.	Drug discovery today	2012	35
22796522	Bile Acids and Salts	Sodhi CP	Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice.	Gastroenterology	2012	64
23141891	Bile Acids and Salts	Poupon R	Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action.	Clinics and research in hepatology and gastroenterology	2012	33
23217254	Bile Acids and Salts	Angelin B	Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.	Cell metabolism	2012	55
23299969	Bile Acids and Salts	Bechmann LP	Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.	Hepatology	2013	34
23391614	Bile Acids and Salts	Lake AD	Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease.	Toxicology and applied pharmacology	2013	30
23641933	Bile Acids and Salts	Cassol E	Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors.	BMC infectious diseases	2013	29
23982684	Bile Acids and Salts	Schaap FG	Bile acid receptors as targets for drug development.	Nature reviews. Gastroenterology & hepatology	2014	61
23988487	Bile Acids and Salts	Li Y	Bile acid receptors in non-alcoholic fatty liver disease.	Biochemical pharmacology	2013	27
24468803	Bile Acids and Salts	Joyce SA	The gut microbiota and the metabolic health of the host.	Current opinion in gastroenterology	2014	32
24625896	Bile Acids and Salts	Ridlon JM	Bile acids and the gut microbiome.	Current opinion in gastroenterology	2014	91
24819989	Bile Acids and Salts	Zhou H	Bile acids are nutrient signaling hormones.	Steroids	2014	32
24867799	Bile Acids and Salts	Vaz FM	Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype.	Hepatology	2015	27
25073467	Bile Acids and Salts	Li T	Bile acid signaling in metabolic disease and drug therapy.	Pharmacological reviews	2014	72
25194674	Bile Acids and Salts	Lieu T	The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice.	Gastroenterology	2014	30
25617503	Bile Acids and Salts	Mueller M	Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity.	Journal of hepatology	2015	19
25705637	Bile Acids and Salts	Ali AH	Recent advances in the development of farnesoid X receptor agonists.	Annals of translational medicine	2015	30
26045265	Bile Acids and Salts	Kliewer SA	Bile Acids as Hormones: The FXR-FGF15/19 Pathway.	Digestive diseases	2015	17
26197299	Bile Acids and Salts	Flynn CR	Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery.	Nature communications	2015	19
26347530	Bile Acids and Salts	Valentin N	Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis.	Gut	2016	12
26418580	Bile Acids and Salts	Zhou M	Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice.	Hepatology	2016	15
26706784	Bile Acids and Salts	Copple BL	Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules.	Pharmacological research	2016	13
26838806	Bile Acids and Salts	Zhang Y	Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function.	Scientific reports	2016	17
27196572	Bile Acids and Salts	Duparc T	Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.	Gut	2017	14
27339554	Bile Acids and Salts	Vanier MT	Diagnostic tests for Niemann-Pick disease type C (NP-C): A critical review.	Molecular genetics and metabolism	2016	14
27358174	Bile Acids and Salts	Arab JP	Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.	Hepatology	2017	22
27770549	Bile Acids and Salts	Zhang L	Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay.	Hepatology	2017	12
27780972	Bile Acids and Salts	Wesolowski SR	Developmental origins of NAFLD: a womb with a clue.	Nature reviews. Gastroenterology & hepatology	2017	7
11104786	Cyclophosphamide	Ponomaryov T	Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function.	The Journal of clinical investigation	2000	138
16720851	Cyclophosphamide	Bernstein M	Ewing's sarcoma family of tumors: current management.	The oncologist	2006	82
17284714	Cyclophosphamide	Hershman D	Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.	Journal of the National Cancer Institute	2007	72
17873873	Cyclophosphamide	Soto D	Stargazin attenuates intracellular polyamine block of calcium-permeable AMPA receptors.	Nature neuroscience	2007	73
18378569	Cyclophosphamide	Wilson WH	Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers.	Journal of clinical oncology 	2008	58
21189393	Cyclophosphamide	Ruan J	Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.	Journal of clinical oncology 	2011	56
25239573	Cyclophosphamide	Green DM	Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study.	The Lancet. Oncology	2014	20
25687405	Cyclophosphamide	Acharya MM	Stem cell transplantation reverses chemotherapy-induced cognitive dysfunction.	Cancer research	2015	16
25738670	Cyclophosphamide	Robak T	Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.	The New England journal of medicine	2015	37
26578779	Cyclophosphamide	Tolaney SM	Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients.	Proceedings of the National Academy of Sciences of the United States of America	2015	32
26860465	Cyclophosphamide	Naipal KA	Tumor slice culture system to assess drug response of primary breast cancer.	BMC cancer	2016	11
9740801	Doxorubicin	Juo P	Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade.	Current biology 	1998	115
9831867	Doxorubicin	Ross JS	The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.	Stem cells	1998	110
11119611	Doxorubicin	Rivas C	Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.	Journal of virology	2001	103
17415413	Doxorubicin	Biswas S	Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.	The Journal of clinical investigation	2007	100
18574145	Doxorubicin	Burgess DJ	Topoisomerase levels determine chemotherapy response in vitro and in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2008	87
22673234	Doxorubicin	Shatz M	The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells.	Cancer research	2012	35
22952218	Doxorubicin	Manzoor AA	Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors.	Cancer research	2012	61
24565525	Doxorubicin	Deng X	Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.	Biomaterials	2014	41
25079333	Doxorubicin	Tavora B	Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy.	Nature	2014	21
25605897	Doxorubicin	Poruchynsky MS	Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins.	Proceedings of the National Academy of Sciences of the United States of America	2015	25
25789975	Doxorubicin	Hall JR	Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes.	Cell death & disease	2015	16
25895646	Doxorubicin	Rochette L	Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms.	Trends in pharmacological sciences	2015	15
26447779	Doxorubicin	Abegglen LM	Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans.	JAMA	2015	41
28108310	Doxorubicin	Bartlett JJ	Autophagic dysregulation in doxorubicin cardiomyopathy.	Journal of molecular and cellular cardiology	2017	9
17236958	Dexamethasone	Gonzalez J	Effect of bevacizumab on radiation necrosis of the brain.	International journal of radiation oncology, biology, physics	2007	67
17690257	Dexamethasone	Richardson PG	Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial.	Blood	2007	102
22498745	Dexamethasone	Cavo M	Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.	Blood	2012	54
22536411	Dexamethasone	Hoch AI	Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells.	PloS one	2012	38
24335104	Dexamethasone	Mulligan G	Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy.	Blood	2014	23
24606108	Dexamethasone	New MI	Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma.	The Journal of clinical endocrinology and metabolism	2014	29
25294016	Dexamethasone	Orlowski RZ	A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma.	American journal of hematology	2015	25
25710470	Dexamethasone	Alexander T	The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.	Annals of the rheumatic diseases	2015	23
25888260	Dexamethasone	Surace L	Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response.	Immunity	2015	24
8649519	Antineoplastic Agents	Waldman T	Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21.	Nature	1996	134
10446993	Antineoplastic Agents	Chang BD	A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.	Cancer research	1999	119
16475973	Antineoplastic Agents	Fritz G	Rho GTPases: promising cellular targets for novel anticancer drugs.	Current cancer drug targets	2006	64
21247385	Antineoplastic Agents	Jia L	SCF E3 ubiquitin ligases as anticancer targets.	Current cancer drug targets	2011	48
21630130	Antineoplastic Agents	Lacouture ME	Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.	Supportive care in cancer 	2011	44
22532596	Antineoplastic Agents	Vinay DS	Immunotherapy of cancer with 4-1BB.	Molecular cancer therapeutics	2012	38
24732808	Antineoplastic Agents	Li Y	Multi-targeted therapy of cancer by niclosamide: A new application for an old drug.	Cancer letters	2014	36
24856239	Antineoplastic Agents	Pommier Y	Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).	DNA repair	2014	49
25897862	Antineoplastic Agents	Fasano E	Long-chain n-3 PUFA against breast and prostate cancer: Which are the appropriate doses for intervention studies in animals and humans?	Critical reviews in food science and nutrition	2017	7
15774776	Fluorouracil	Ghadimi BM	Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.	Journal of clinical oncology 	2005	67
16246976	Fluorouracil	Rödel C	Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.	Journal of clinical oncology 	2005	191
17906203	Fluorouracil	Collette L	Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.	Journal of clinical oncology 	2007	71
19470921	Fluorouracil	Willett CG	Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study.	Journal of clinical oncology 	2009	155
20697159	Fluorouracil	Haraguchi N	CD13 is a therapeutic target in human liver cancer stem cells.	The Journal of clinical investigation	2010	135
21969819	Fluorouracil	Shibata T	NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer.	Neoplasia	2011	40
22248601	Fluorouracil	Hecht JR	EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study.	Gastrointestinal endoscopy	2012	31
23167930	Fluorouracil	Svoboda M	MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.	Radiation oncology	2012	32
24275137	Fluorouracil	Deng J	Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro.	Biochemical and biophysical research communications	2014	26
24743738	Fluorouracil	Kang KA	Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation.	Cell death & disease	2014	22
24859412	Fluorouracil	Honjo S	Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer.	International journal of oncology	2014	24
25406793	Fluorouracil	Kim IY	Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer.	BMC surgery	2014	24
25733851	Fluorouracil	Conde J	Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance.	Proceedings of the National Academy of Sciences of the United States of America	2015	16
28287424	Fluorouracil	Ogawa R	Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.	International journal of molecular sciences	2017	11
1348364	Cisplatin	Godwin AK	High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.	Proceedings of the National Academy of Sciences of the United States of America	1992	151
8194005	Cisplatin	Mandard AM	Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations.	Cancer	1994	246
9427750	Cisplatin	Cliby WA	Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints.	The EMBO journal	1998	163
10446958	Cisplatin	Yuan SS	BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.	Cancer research	1999	142
11283264	Cisplatin	Takata M	Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs.	Molecular and cellular biology	2001	176
12524540	Cisplatin	Bergamaschi D	iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.	Nature genetics	2003	96
14534679	Cisplatin	Boulikas T	Cisplatin and platinum drugs at the molecular level. (Review).	Oncology reports	2003	95
15279797	Cisplatin	Stojic L	Mismatch repair and DNA damage signalling.	DNA repair	2004	106
16000298	Cisplatin	Dittmann K	Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase.	The Journal of biological chemistry	2005	140
16932740	Cisplatin	Zwang Y	p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy.	The EMBO journal	2006	75
20100965	Cisplatin	Silver DP	Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.	Journal of clinical oncology 	2010	231
21034966	Cisplatin	Smith J	The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.	Advances in cancer research	2010	268
21266349	Cisplatin	Liccardi G	EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment.	Cancer research	2011	73
21428443	Cisplatin	Huang F	Identification of specific inhibitors of human RAD51 recombinase using high-throughput screening.	ACS chemical biology	2011	47
21472714	Cisplatin	Alhazzazi TY	Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer.	Cancer	2011	53
21903745	Cisplatin	Curran WJ Jr	Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.	Journal of the National Cancer Institute	2011	174
22178121	Cisplatin	Lee NY	Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial.	The Lancet. Oncology	2012	61
22647982	Cisplatin	Zhou C	Monitoring autophagic flux by an improved tandem fluorescent-tagged LC3 (mTagRFP-mWasabi-LC3) reveals that high-dose rapamycin impairs autophagic flux in cancer cells.	Autophagy	2012	43
23251001	Cisplatin	Kimple RJ	Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts.	Clinical cancer research 	2013	31
23382914	Cisplatin	Pan Y	Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma.	PloS one	2013	30
24401670	Cisplatin	Riaz N	Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck.	American journal of clinical oncology	2016	10
24552320	Cisplatin	Tewari KS	Improved survival with bevacizumab in advanced cervical cancer.	The New England journal of medicine	2014	164
24788099	Cisplatin	Watanabe R	SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.	Cancer research	2014	33
25096233	Cisplatin	Van Allen EM	Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma.	Cancer discovery	2014	65
25154822	Cisplatin	Ang KK	Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.	Journal of clinical oncology 	2014	120
25228385	Cisplatin	Tan X	miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.	Breast cancer research 	2014	30
25366680	Cisplatin	Nguyen-Tan PF	Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.	Journal of clinical oncology 	2014	34
25596659	Cisplatin	Giralt J	Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.	The Lancet. Oncology	2015	25
25596660	Cisplatin	Mesía R	Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial.	The Lancet. Oncology	2015	20
26036632	Cisplatin	García-Cano J	Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance.	Oncotarget	2015	19
26119935	Cisplatin	Ciamporcero E	YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.	Oncogene	2016	19
26178914	Cisplatin	Balermpas P	CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).	International journal of cancer	2016	27
26716514	Cisplatin	Cheng H	Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells.	Oncotarget	2016	17
26756568	Cisplatin	Zhou XL	High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.	Molecular carcinogenesis	2016	16
27372520	Cisplatin	Malapelle U	USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs.	Lung cancer	2017	5
27911863	Cisplatin	Wang Q	Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma.	Oncotarget	2017	8
28196596	Cisplatin	Gardner EE	Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.	Cancer cell	2017	14
10335783	Sialic Acids	Schmidt MI	Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study.	Lancet	1999	166
15930282	Sialic Acids	Seales EC	Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility.	Cancer research	2005	85
10385605	Oxygen	Li N	Is NF-kappaB the sensor of oxidative stress?	FASEB journal 	1999	121
11034104	Oxygen	Lee CG	Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.	Cancer research	2000	118
11121681	Oxygen	Toussaint O	Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes.	Experimental gerontology	2000	102
11163244	Oxygen	Whitehouse CJ	XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair.	Cell	2001	146
11306467	Oxygen	Aebersold DM	Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.	Cancer research	2001	109
11507045	Oxygen	Fukumura D	Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo.	Cancer research	2001	91
11522632	Oxygen	Loncaster JA	Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix.	Cancer research	2001	103
12515825	Oxygen	Ricci JE	Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis.	The Journal of cell biology	2003	79
12519769	Oxygen	Hammond EM	ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation.	The Journal of biological chemistry	2003	75
12600231	Oxygen	Dent P	Stress and radiation-induced activation of multiple intracellular signaling pathways.	Radiation research	2003	109
14526383	Oxygen	Giaccia A	HIF-1 as a target for drug development.	Nature reviews. Drug discovery	2003	123
15073152	Oxygen	Pesah Y	Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress.	Development	2004	133
15126346	Oxygen	Xie Y	Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors.	Cancer research	2004	73
15304631	Oxygen	Semenza GL	Hydroxylation of HIF-1: oxygen sensing at the molecular level.	Physiology	2004	199
16024780	Oxygen	Chan DA	Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha.	Molecular and cellular biology	2005	69
16513837	Oxygen	Cairns R	Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment.	Molecular cancer research 	2006	74
16642001	Oxygen	Erler JT	Lysyl oxidase is essential for hypoxia-induced metastasis.	Nature	2006	431
17084552	Oxygen	Blazek ER	Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia.	International journal of radiation oncology, biology, physics	2007	60
17363476	Oxygen	Valerie K	Radiation-induced cell signaling: inside-out and outside-in.	Molecular cancer therapeutics	2007	115
17643088	Oxygen	Jain RK	Angiogenesis in brain tumours.	Nature reviews. Neuroscience	2007	335
17998060	Oxygen	Brown JM	Tumor hypoxia in cancer therapy.	Methods in enzymology	2007	69
18157161	Oxygen	Shrivastav M	Regulation of DNA double-strand break repair pathway choice.	Cell research	2008	339
18160646	Oxygen	Boettiger CA	Immediate reward bias in humans: fronto-parietal networks and a role for the catechol-O-methyltransferase 158(Val/Val) genotype.	The Journal of neuroscience 	2007	109
18199558	Oxygen	Chan N	Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance.	Cancer research	2008	72
18524993	Oxygen	Sallmyr A	Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks.	Blood	2008	57
18551130	Oxygen	Papandreou I	Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L.	Cell death and differentiation	2008	97
18709470	Oxygen	Yang H	Mesothelioma epidemiology, carcinogenesis, and pathogenesis.	Current treatment options in oncology	2008	58
18924608	Oxygen	Bedogni B	Notch1 is an effector of Akt and hypoxia in melanoma development.	The Journal of clinical investigation	2008	72
18981219	Oxygen	Bencokova Z	ATM activation and signaling under hypoxic conditions.	Molecular and cellular biology	2009	57
19158125	Oxygen	Seymour JM	Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD.	Thorax	2009	49
19459851	Oxygen	Kizaka-Kondoh S	Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia.	Cancer science	2009	46
19479945	Oxygen	Ruan K	Role of hypoxia in the hallmarks of human cancer.	Journal of cellular biochemistry	2009	96
19505186	Oxygen	Sarsour EH	Redox control of the cell cycle in health and disease.	Antioxidants & redox signaling	2009	79
19816235	Oxygen	Ballabh P	Intraventricular hemorrhage in premature infants: mechanism of disease.	Pediatric research	2010	84
19929412	Oxygen	Dewhirst MW	Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress.	Radiation research	2009	69
20103649	Oxygen	Pires IM	Effects of acute versus chronic hypoxia on DNA damage responses and genomic instability.	Cancer research	2010	44
20169192	Oxygen	Coppé JP	A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen.	PloS one	2010	118
20452943	Oxygen	Gottlieb E	p53 regulation of metabolic pathways.	Cold Spring Harbor perspectives in biology	2010	65
20473774	Oxygen	Batinic-Haberle I	Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities.	Amino acids	2012	49
20520707	Oxygen	Sendoel A	HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase.	Nature	2010	57
20836033	Oxygen	Semenza GL	Oxygen homeostasis.	Wiley interdisciplinary reviews. Systems biology and medicine	2010	101
21139141	Oxygen	Bensimon A	ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage.	Science signaling	2010	91
21664270	Oxygen	Wagner BA	The rate of oxygen utilization by cells.	Free radical biology & medicine	2011	50
21742796	Oxygen	Goel S	Normalization of the vasculature for treatment of cancer and other diseases.	Physiological reviews	2011	317
21785006	Oxygen	Semenza GL	Regulation of metabolism by hypoxia-inducible factor 1.	Cold Spring Harbor symposia on quantitative biology	2011	91
21962515	Oxygen	Haque A	Conformation-sensing antibodies stabilize the oxidized form of PTP1B and inhibit its phosphatase activity.	Cell	2011	42
22281437	Oxygen	Lozy F	Autophagy and cancer cell metabolism.	Seminars in cell & developmental biology	2012	54
23581847	Oxygen	Candas D	MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx.	Antioxidants & redox signaling	2014	27
23722747	Oxygen	Yi J	Visible-light optical coherence tomography for retinal oximetry.	Optics letters	2013	41
23782686	Oxygen	Hellström A	Retinopathy of prematurity.	Lancet	2013	75
24045183	Oxygen	Mujcic H	Hypoxic activation of the PERK/eIF2α arm of the unfolded protein response promotes metastasis through induction of LAMP3.	Clinical cancer research 	2013	27
24569087	Oxygen	Brocato J	Molecular responses to hypoxia-inducible factor 1α and beyond.	Molecular pharmacology	2014	23
24743516	Oxygen	Sousa CM	The complex landscape of pancreatic cancer metabolism.	Carcinogenesis	2014	22
24776803	Oxygen	van Galen P	The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress.	Nature	2014	58
24889884	Oxygen	Catalano MG	Extracorporeal shockwaves (ESWs) enhance the osteogenic medium-induced differentiation of adipose-derived stem cells into osteoblast-like cells.	Journal of tissue engineering and regenerative medicine	2017	5
24975555	Oxygen	Tang FR	Molecular mechanisms of low dose ionizing radiation-induced hormesis, adaptive responses, radioresistance, bystander effects, and genomic instability.	International journal of radiation biology	2015	16
24986882	Oxygen	Grusch M	Spatio-temporally precise activation of engineered receptor tyrosine kinases by light.	The EMBO journal	2014	35
25351418	Oxygen	van den Beucken T	Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.	Nature communications	2014	43
25704383	Oxygen	Span PN	Biology of hypoxia.	Seminars in nuclear medicine	2015	16
28137309	Oxygen	Lee SY	Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.	Molecular cancer	2017	11
2554145	Pyrimidine Dimers	Mellon I	Induction of the Escherichia coli lactose operon selectively increases repair of its transcribed DNA strand.	Nature	1989	165
15748635	Pyrimidine Dimers	Pfeifer GP	Mutations induced by ultraviolet light.	Mutation research	2005	134
19564618	Pyrimidine Dimers	Ziv O	DNA polymerase zeta cooperates with polymerases kappa and iota in translesion DNA synthesis across pyrimidine photodimers in cells from XPV patients.	Proceedings of the National Academy of Sciences of the United States of America	2009	50
22807682	Pyrimidine Dimers	Wallace NA	HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage.	PLoS pathogens	2012	38
25118285	Pyrimidine Dimers	He J	Ubiquitin-specific protease 7 regulates nucleotide excision repair through deubiquitinating XPC protein and preventing XPC protein from undergoing ultraviolet light-induced and VCP/p97 protein-regulated proteolysis.	The Journal of biological chemistry	2014	27
9989963	Cholesterol	de Lorgeril M	Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study.	Circulation	1999	261
11238037	Cholesterol	Sugiyama S	Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes.	The American journal of pathology	2001	102
11473047	Cholesterol	Marchesini G	Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.	Diabetes	2001	400
12682040	Cholesterol	Broquet AH	Expression of the molecular chaperone Hsp70 in detergent-resistant microdomains correlates with its membrane delivery and release.	The Journal of biological chemistry	2003	85
12716665	Cholesterol	Mensink RP	Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials.	The American journal of clinical nutrition	2003	295
15635109	Cholesterol	Ridker PM	C-reactive protein levels and outcomes after statin therapy.	The New England journal of medicine	2005	262
15635110	Cholesterol	Nissen SE	Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.	The New England journal of medicine	2005	148
15660501	Cholesterol	Moller DE	Metabolic syndrome: a clinical and molecular perspective.	Annual review of medicine	2005	116
15689493	Cholesterol	Pol A	Cholesterol and fatty acids regulate dynamic caveolin trafficking through the Golgi complex and between the cell surface and lipid bodies.	Molecular biology of the cell	2005	66
15925013	Cholesterol	Ginsberg HN	Regulation of plasma triglycerides in insulin resistance and diabetes.	Archives of medical research	2005	88
16249437	Cholesterol	Hanley AJ	Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.	Diabetes	2005	85
16511589	Cholesterol	Lefebvre P	Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis.	The Journal of clinical investigation	2006	191
16709608	Cholesterol	Dumitrescu AM	Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice.	Endocrinology	2006	70
16773565	Cholesterol	Saxena R	Comprehensive association testing of common mitochondrial DNA variation in metabolic disease.	American journal of human genetics	2006	81
16801565	Cholesterol	Knopp RH	Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN).	Diabetes care	2006	73
18751914	Cholesterol	Adibhatla RM	Altered lipid metabolism in brain injury and disorders.	Sub-cellular biochemistry	2008	78
19074428	Cholesterol	Vetrivel KS	Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts.	The Journal of biological chemistry	2009	48
19360495	Cholesterol	Esquirol Y	Shift work and metabolic syndrome: respective impacts of job strain, physical activity, and dietary rhythms.	Chronobiology international	2009	58
19825813	Cholesterol	Chapman MJ	Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.	European heart journal	2010	51
19948145	Cholesterol	Laplante M	An emerging role of mTOR in lipid biosynthesis.	Current biology 	2009	156
19969070	Cholesterol	Seet RC	Oxidative damage in Parkinson disease: Measurement using accurate biomarkers.	Free radical biology & medicine	2010	40
20031582	Cholesterol	Thompson JF	Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort.	Circulation. Cardiovascular genetics	2009	52
20392876	Cholesterol	Pearen MA	Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease.	Molecular endocrinology	2010	90
20734437	Cholesterol	Eisenberg DT	Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history.	American journal of physical anthropology	2010	40
21187371	Cholesterol	Stangl S	Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody.	Proceedings of the National Academy of Sciences of the United States of America	2011	41
21258337	Cholesterol	Bartelt A	Brown adipose tissue activity controls triglyceride clearance.	Nature medicine	2011	321
21324907	Cholesterol	Grimm MO	Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms.	The Journal of biological chemistry	2011	38
21548778	Cholesterol	Moore KJ	The role of microRNAs in cholesterol efflux and hepatic lipid metabolism.	Annual review of nutrition	2011	41
21987488	Cholesterol	Bambha K	Ethnicity and nonalcoholic fatty liver disease.	Hepatology	2012	40
22065762	Cholesterol	Deffieu MS	Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding.	Proceedings of the National Academy of Sciences of the United States of America	2011	44
22156303	Cholesterol	Rottiers V	MicroRNAs in metabolism and metabolic diseases.	Cold Spring Harbor symposia on quantitative biology	2011	36
22183689	Cholesterol	Lomonaco R	Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.	Hepatology	2012	56
22219194	Cholesterol	Shao B	Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.	The Journal of biological chemistry	2012	48
23024286	Cholesterol	Janssens M	Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients.	Journal of lipid research	2012	33
23055570	Cholesterol	Kalia M	Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism.	Journal of virology	2013	29
23584084	Cholesterol	Klop B	Dyslipidemia in obesity: mechanisms and potential targets.	Nutrients	2013	93
23727030	Cholesterol	Yamada H	Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.	Clinica chimica acta; international journal of clinical chemistry	2013	41
24077434	Cholesterol	Shinto L	A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease.	Journal of Alzheimer's disease 	2014	20
24861084	Cholesterol	Fornoni A	Lipid biology of the podocyte--new perspectives offer new opportunities.	Nature reviews. Nephrology	2014	22
24970568	Cholesterol	Morris MC	Dietary fat composition and dementia risk.	Neurobiology of aging	2014	28
25060413	Cholesterol	Gaudet D	Effect of alirocumab, a monoclonal proprotein convertase subtilisin/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150 mg every two weeks dosing from phase 2 trials).	The American journal of cardiology	2014	24
25440796	Cholesterol	Schwartz GG	Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.	American heart journal	2014	41
25733853	Cholesterol	Wang W	Up-regulation of lysosomal TRPML1 channels is essential for lysosomal adaptation to nutrient starvation.	Proceedings of the National Academy of Sciences of the United States of America	2015	25
25754609	Cholesterol	Berbée JF	Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.	Nature communications	2015	39
25871773	Cholesterol	Hu J	Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.	Molecular neurodegeneration	2015	19
26002865	Cholesterol	Karunakaran D	Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.	Circulation research	2015	24
26030325	Cholesterol	Bays H	Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial.	The Journal of clinical endocrinology and metabolism	2015	31
26227186	Cholesterol	Tsujita K	Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.	Journal of the American College of Cardiology	2015	22
26556368	Cholesterol	Yki-Järvinen H	Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.	Nutrients	2015	16
26607793	Cholesterol	Wang C	CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity.	Cell	2015	33
27281302	Cholesterol	Allaire J	A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.	The American journal of clinical nutrition	2016	20
27328938	Cholesterol	Muralidharan R	Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration.	Journal of nanobiotechnology	2016	12
27592805	Cholesterol	Kaufman HL	Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.	The Lancet. Oncology	2016	81
28286957	Cholesterol	Chen H	Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism.	Journal of proteome research	2017	8
28462530	Cholesterol	Blander JM	The many ways tissue phagocytes respond to dying cells.	Immunological reviews	2017	6
14633152	Creatinine	Larsson T	Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.	Kidney international	2003	149
15788478	Creatinine	Perkins BA	Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study.	Journal of the American Society of Nephrology 	2005	91
16528543	Creatinine	Mishra J	Kidney NGAL is a novel early marker of acute injury following transplantation.	Pediatric nephrology	2006	75
16827865	Creatinine	Parikh CR	Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation.	American journal of transplantation 	2006	115
17332152	Creatinine	Levey AS	Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values.	Clinical chemistry	2007	373
17656479	Creatinine	Fliser D	Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.	Journal of the American Society of Nephrology 	2007	180
19118301	Creatinine	Moers C	Machine perfusion or cold storage in deceased-donor kidney transplantation.	The New England journal of medicine	2009	85
19762491	Creatinine	Hall IE	IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation.	Journal of the American Society of Nephrology 	2010	85
20164823	Creatinine	Endre ZH	Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial).	Kidney international	2010	71
24480828	Creatinine	Kaushal GP	Challenges and advances in the treatment of AKI.	Journal of the American Society of Nephrology 	2014	20
24625530	Creatinine	Kasonde M	Bone mineral density changes among HIV-uninfected young adults in a randomised trial of pre-exposure prophylaxis with tenofovir-emtricitabine or placebo in Botswana.	PloS one	2014	27
26566060	Creatinine	Freedman BI	APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.	Transplantation	2016	26
11744721	Triglycerides	Cole NB	Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein.	The Journal of biological chemistry	2002	103
12401889	Triglycerides	Attie AD	Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia.	Journal of lipid research	2002	83
16054079	Triglycerides	Grönke S	Brummer lipase is an evolutionary conserved fat storage regulator in Drosophila.	Cell metabolism	2005	151
16611275	Triglycerides	Capanni M	Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study.	Alimentary pharmacology & therapeutics	2006	77
17680645	Triglycerides	Joshi-Barve S	Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes.	Hepatology	2007	65
18279736	Triglycerides	Miller M	Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.	Journal of the American College of Cardiology	2008	69
18421281	Triglycerides	Larson-Meyer DE	Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function.	Obesity	2008	54
19064985	Triglycerides	Segal RJ	Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer.	Journal of clinical oncology 	2009	77
22063269	Triglycerides	Mattijssen F	Regulation of triglyceride metabolism by Angiopoietin-like proteins.	Biochimica et biophysica acta	2012	40
22213436	Triglycerides	Sullivan S	Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.	Hepatology	2012	37
23261442	Triglycerides	Fu Z	Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family.	Biochemical and biophysical research communications	2013	31
24511104	Triglycerides	Ruhanen H	PNPLA3 mediates hepatocyte triacylglycerol remodeling.	Journal of lipid research	2014	23
24920721	Triglycerides	Irvin MR	Epigenome-wide association study of fasting blood lipids in the Genetics of Lipid-lowering Drugs and Diet Network study.	Circulation	2014	50
24927523	Triglycerides	Mahdessian H	TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content.	Proceedings of the National Academy of Sciences of the United States of America	2014	44
25038053	Triglycerides	Goedeke L	Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice.	EMBO molecular medicine	2014	35
25885947	Triglycerides	Portillo-Sanchez P	High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.	The Journal of clinical endocrinology and metabolism	2015	27
27023631	Triglycerides	Dijk W	Regulation of lipid metabolism by angiopoietin-like proteins.	Current opinion in lipidology	2016	17
27034464	Triglycerides	Dijk W	Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes.	Journal of lipid research	2016	14
9916795	Fatty Acids	Aitman TJ	Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats.	Nature genetics	1999	120
11237216	Fatty Acids	Kliewer SA	Peroxisome proliferator-activated receptors: from genes to physiology.	Recent progress in hormone research	2001	89
12483461	Fatty Acids	Mead JR	Lipoprotein lipase: structure, function, regulation, and role in disease.	Journal of molecular medicine	2002	116
12663460	Fatty Acids	Savage DB	Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma.	Diabetes	2003	80
15671481	Fatty Acids	Zick Y	Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance.	Science's STKE 	2005	83
15749821	Fatty Acids	Karan G	Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2005	75
15823385	Fatty Acids	Stumvoll M	Type 2 diabetes: principles of pathogenesis and therapy.	Lancet	2005	356
15829499	Fatty Acids	Pich S	The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system.	Human molecular genetics	2005	105
15836891	Fatty Acids	Eckel RH	The metabolic syndrome.	Lancet	2005	928
15841205	Fatty Acids	Drover VA	CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood.	The Journal of clinical investigation	2005	74
16011470	Fatty Acids	Sampath H	Polyunsaturated fatty acid regulation of genes of lipid metabolism.	Annual review of nutrition	2005	96
16026420	Fatty Acids	Trayhurn P	Endocrine and signalling role of adipose tissue: new perspectives on fat.	Acta physiologica Scandinavica	2005	82
16306347	Fatty Acids	Cnop M	Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities.	Diabetes	2005	320
16584505	Fatty Acids	Ronti T	The endocrine function of adipose tissue: an update.	Clinical endocrinology	2006	127
16603729	Fatty Acids	Reddy JK	Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.	American journal of physiology. Gastrointestinal and liver physiology	2006	177
16912127	Fatty Acids	Burgert TS	Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat.	The Journal of clinical endocrinology and metabolism	2006	79
16955100	Fatty Acids	Weinberg JM	Lipotoxicity.	Kidney international	2006	72
16968800	Fatty Acids	Utzschneider KM	Review: The role of insulin resistance in nonalcoholic fatty liver disease.	The Journal of clinical endocrinology and metabolism	2006	103
17167471	Fatty Acids	Kahn SE	Mechanisms linking obesity to insulin resistance and type 2 diabetes.	Nature	2006	828
17179929	Fatty Acids	Rask-Madsen C	Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.	Nature clinical practice. Endocrinology & metabolism	2007	108
17460227	Fatty Acids	Waterham HR	A lethal defect of mitochondrial and peroxisomal fission.	The New England journal of medicine	2007	204
17684197	Fatty Acids	Zivkovic AM	Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease.	The American journal of clinical nutrition	2007	82
18242210	Fatty Acids	Fabbrini E	Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.	Gastroenterology	2008	104
18360697	Fatty Acids	Kohjima M	SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.	International journal of molecular medicine	2008	68
18430557	Fatty Acids	Gentile CL	The role of fatty acids in the development and progression of nonalcoholic fatty liver disease.	The Journal of nutritional biochemistry	2008	54
18433732	Fatty Acids	Hardwick JP	Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases.	Biochemical pharmacology	2008	65
18565848	Fatty Acids	Adiels M	Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.	Arteriosclerosis, thrombosis, and vascular biology	2008	135
18673007	Fatty Acids	King GL	The role of inflammatory cytokines in diabetes and its complications.	Journal of periodontology	2008	96
18926294	Fatty Acids	Szanto A	The many faces of PPARgamma: anti-inflammatory by any means?	Immunobiology	2008	51
18952573	Fatty Acids	Zechner R	Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores.	Journal of lipid research	2009	147
19047759	Fatty Acids	Wakil SJ	Fatty acid metabolism: target for metabolic syndrome.	Journal of lipid research	2009	107
19056664	Fatty Acids	Kennedy A	Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications.	The Journal of nutrition	2009	90
19119140	Fatty Acids	Li ZZ	Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.	The Journal of biological chemistry	2009	112
19171470	Fatty Acids	Lionetti L	From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.	Nutrition, metabolism, and cardiovascular diseases 	2009	52
19185504	Fatty Acids	Su X	Cellular fatty acid uptake: a pathway under construction.	Trends in endocrinology and metabolism	2009	74
19421860	Fatty Acids	Kusminski CM	Diabetes and apoptosis: lipotoxicity.	Apoptosis 	2009	71
19442172	Fatty Acids	Cani PD	The role of the gut microbiota in energy metabolism and metabolic disease.	Current pharmaceutical design	2009	149
19715772	Fatty Acids	Poitout V	Glucolipotoxicity of the pancreatic beta cell.	Biochimica et biophysica acta	2010	75
19723495	Fatty Acids	Barrès R	Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density.	Cell metabolism	2009	152
19803417	Fatty Acids	Eklund CM	Proinflammatory cytokines in CRP baseline regulation.	Advances in clinical chemistry	2009	51
20080535	Fatty Acids	Wang J	Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells.	Proceedings of the National Academy of Sciences of the United States of America	2010	51
20110572	Fatty Acids	Schwartz EA	Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation.	Arteriosclerosis, thrombosis, and vascular biology	2010	46
20303349	Fatty Acids	Lee JH	A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis.	Gastroenterology	2010	51
20370677	Fatty Acids	Bugianesi E	Insulin resistance in nonalcoholic fatty liver disease.	Current pharmaceutical design	2010	55
20935172	Fatty Acids	Love-Gregory L	Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile.	Human molecular genetics	2011	42
20978091	Fatty Acids	Schauer IE	Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.	Diabetes	2011	56
21042023	Fatty Acids	Wree A	Obesity affects the liver - the link between adipocytes and hepatocytes.	Digestion	2011	45
21145849	Fatty Acids	Begriche K	Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.	Journal of hepatology	2011	48
21270117	Fatty Acids	Miquilena-Colina ME	Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.	Gut	2011	68
21372033	Fatty Acids	Subbaramaiah K	Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland.	Cancer prevention research	2011	124
21514287	Fatty Acids	Koek GH	The role of oxidative stress in non-alcoholic steatohepatitis.	Clinica chimica acta; international journal of clinical chemistry	2011	64
21664213	Fatty Acids	Aubert J	Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.	Clinics and research in hepatology and gastroenterology	2011	51
21734787	Fatty Acids	Buechler C	Adiponectin, a key adipokine in obesity related liver diseases.	World journal of gastroenterology	2011	51
21745271	Fatty Acids	Svegliati-Baroni G	Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.	Liver international 	2011	64
21812367	Fatty Acids	-	Fats and fatty acids in human nutrition. Report of an expert consultation.	FAO food and nutrition paper	2010	45
21979150	Fatty Acids	Kazantzis M	Fatty acid transport proteins, implications in physiology and disease.	Biochimica et biophysica acta	2012	51
21985374	Fatty Acids	Tang Y	Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.	Clinical and experimental immunology	2011	47
22009142	Fatty Acids	Jensen-Urstad AP	Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?	Biochimica et biophysica acta	2012	34
22162139	Fatty Acids	Halestrap AP	The monocarboxylate transporter family--role and regulation.	IUBMB life	2012	103
22200617	Fatty Acids	Harwood HJ Jr	The adipocyte as an endocrine organ in the regulation of metabolic homeostasis.	Neuropharmacology	2012	51
22230555	Fatty Acids	Fanali G	Human serum albumin: from bench to bedside.	Molecular aspects of medicine	2012	104
22326434	Fatty Acids	Cusi K	Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.	Gastroenterology	2012	130
22351630	Fatty Acids	Smith MM	Obesity and adipokines: effects on sympathetic overactivity.	The Journal of physiology	2012	37
22450341	Fatty Acids	Shehzad A	Adiponectin: regulation of its production and its role in human diseases.	Hormones	2012	46
22483867	Fatty Acids	Kemp S	X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.	Biochimica et biophysica acta	2012	42
22516720	Fatty Acids	Georgiadi A	Mechanisms of gene regulation by fatty acids.	Advances in nutrition	2012	39
22607863	Fatty Acids	Shah SH	Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease.	American heart journal	2012	54
22640930	Fatty Acids	Kiecolt-Glaser JK	Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial.	Brain, behavior, and immunity	2012	38
22704720	Fatty Acids	Wahli W	PPARs at the crossroads of lipid signaling and inflammation.	Trends in endocrinology and metabolism	2012	105
22749135	Fatty Acids	Lottenberg AM	The role of dietary fatty acids in the pathology of metabolic syndrome.	The Journal of nutritional biochemistry	2012	36
22753171	Fatty Acids	Matsuzaka T	Elovl6 promotes nonalcoholic steatohepatitis.	Hepatology	2012	37
22811425	Fatty Acids	Abumrad NA	Role of the gut in lipid homeostasis.	Physiological reviews	2012	72
22886304	Fatty Acids	Carracedo A	A metabolic prosurvival role for PML in breast cancer.	The Journal of clinical investigation	2012	65
22889154	Fatty Acids	Engelen M	X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.	Orphanet journal of rare diseases	2012	43
22937964	Fatty Acids	Yehuda-Shnaidman E	Mechanisms linking obesity, inflammation and altered metabolism to colon carcinogenesis.	Obesity reviews 	2012	36
22984005	Fatty Acids	Kihara A	Very long-chain fatty acids: elongation, physiology and related disorders.	Journal of biochemistry	2012	58
23023705	Fatty Acids	Li JZ	Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.	The Journal of clinical investigation	2012	52
23176821	Fatty Acids	Tesson C	Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia.	American journal of human genetics	2012	39
23550081	Fatty Acids	Hocking S	Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots.	Endocrine reviews	2013	33
23723111	Fatty Acids	van Greevenbroek MM	Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences.	The Netherlands journal of medicine	2013	40
23749645	Fatty Acids	Muir K	Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma.	Cancer research	2013	39
23781214	Fatty Acids	Kwon H	Adipokines mediate inflammation and insulin resistance.	Frontiers in endocrinology	2013	73
23792151	Fatty Acids	Hijmans BS	Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences.	Biochimie	2014	32
23813974	Fatty Acids	Bochenek G	The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10.	Human molecular genetics	2013	37
23855294	Fatty Acids	Roh YS	Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.	Journal of gastroenterology and hepatology	2013	55
23860382	Fatty Acids	Lisanti MP	Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery.	Cell cycle	2013	33
23876739	Fatty Acids	Ali AT	Adipocyte and adipogenesis.	European journal of cell biology	2013	48
23995233	Fatty Acids	Freigang S	Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis.	Nature immunology	2013	56
24187406	Fatty Acids	Jialal I	Toll-like receptor status in obesity and metabolic syndrome: a translational perspective.	The Journal of clinical endocrinology and metabolism	2014	30
24297848	Fatty Acids	Kurdiova T	Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.	The Journal of physiology	2014	50
24316260	Fatty Acids	Lambert JE	Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.	Gastroenterology	2014	78
24374014	Fatty Acids	Liu J	Tumor suppressor p53 and its mutants in cancer metabolism.	Cancer letters	2015	34
24486645	Fatty Acids	Martinez-Outschoorn UE	Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth.	Seminars in cancer biology	2014	58
24500438	Fatty Acids	Thumser AE	Fatty acid binding proteins: tissue-specific functions in health and disease.	Current opinion in clinical nutrition and metabolic care	2014	20
24515116	Fatty Acids	Stribl C	Mitochondrial dysfunction and decrease in body weight of a transgenic knock-in mouse model for TDP-43.	The Journal of biological chemistry	2014	22
24692138	Fatty Acids	Rui L	Energy metabolism in the liver.	Comprehensive Physiology	2014	103
24773202	Fatty Acids	West CE	The gut microbiota and its role in the development of allergic disease: a wider perspective.	Clinical and experimental allergy 	2015	20
24837835	Fatty Acids	Nassir F	Role of mitochondria in nonalcoholic fatty liver disease.	International journal of molecular sciences	2014	27
24848981	Fatty Acids	Albert JS	Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes.	The New England journal of medicine	2014	30
25083607	Fatty Acids	Fisher FM	Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.	Gastroenterology	2014	37
25242319	Fatty Acids	Huang	HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression.	Cell reports	2014	39
25284588	Fatty Acids	Jiang L	Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition.	Oncogene	2015	26
25319745	Fatty Acids	Scher JU	Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.	Arthritis & rheumatology	2015	61
25584012	Fatty Acids	Bourgeois EA	Bee venom processes human skin lipids for presentation by CD1a.	The Journal of experimental medicine	2015	26
25584894	Fatty Acids	Schug ZT	Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress.	Cancer cell	2015	82
25598765	Fatty Acids	Bjerrum JT	Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals.	Metabolomics 	2015	19
25691458	Fatty Acids	Guenther S	Spatially resolved metabolic phenotyping of breast cancer by desorption electrospray ionization mass spectrometry.	Cancer research	2015	20
25961460	Fatty Acids	Fu X	MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.	The Journal of clinical investigation	2015	24
25972478	Fatty Acids	Tkachev V	Programmed death-1 controls T cell survival by regulating oxidative metabolism.	Journal of immunology	2015	19
26170839	Fatty Acids	Papaetis GS	Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.	Archives of medical science 	2015	16
26185980	Fatty Acids	Siri-Tarino PW	Saturated Fats Versus Polyunsaturated Fats Versus Carbohydrates for Cardiovascular Disease Prevention and Treatment.	Annual review of nutrition	2015	15
26355033	Fatty Acids	Boden G	Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men.	Science translational medicine	2015	15
26488817	Fatty Acids	Haghikia A	Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.	Immunity	2015	52
26604000	Fatty Acids	Vanstone JR	DNM1L-related mitochondrial fission defect presenting as refractory epilepsy.	European journal of human genetics 	2016	14
26619117	Fatty Acids	Denechaud PD	E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis.	The Journal of clinical investigation	2016	13
26719191	Fatty Acids	Hammad S	Current Evidence Supporting the Link Between Dietary Fatty Acids and Cardiovascular Disease.	Lipids	2016	11
26852705	Fatty Acids	Pomatto LC	The peroxisomal Lon protease LonP2 in aging and disease: functions and comparisons with mitochondrial Lon protease LonP1.	Biological reviews of the Cambridge Philosophical Society	2017	6
27083551	Fatty Acids	Cooke AA	Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome.	European journal of pharmacology	2016	13
27135739	Fatty Acids	Fukawa T	Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.	Nature medicine	2016	20
27141887	Fatty Acids	Martinez-Outschoorn UE	Cancer metabolism: a therapeutic perspective.	Nature reviews. Clinical oncology	2017	62
27188459	Fatty Acids	Brunt EM	Nonalcoholic fatty liver disease.	Nature reviews. Disease primers	2015	24
27723756	Fatty Acids	Wang J	Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota.	Nature genetics	2016	27
27878243	Fatty Acids	Häggblad Sahlberg S	Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.	International journal of oncology	2017	6
27908782	Fatty Acids	Raefsky SM	Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance.	Free radical biology & medicine	2017	16
28267621	Fatty Acids	Tacke F	Targeting hepatic macrophages to treat liver diseases.	Journal of hepatology	2017	23
28346411	Fatty Acids	Lynes MD	The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue.	Nature medicine	2017	14
12406438	Fatty Acids, Nonesterified	Day CP	Pathogenesis of steatohepatitis.	Best practice & research. Clinical gastroenterology	2002	90
12629551	Fatty Acids, Nonesterified	Itoh Y	Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.	Nature	2003	277
15239102	Fatty Acids, Nonesterified	Feldstein AE	Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway.	Hepatology	2004	162
15619630	Fatty Acids, Nonesterified	Hirasawa A	Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120.	Nature medicine	2005	265
16018787	Fatty Acids, Nonesterified	Carlson LA	Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review.	Journal of internal medicine	2005	81
16932311	Fatty Acids, Nonesterified	Roden M	Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.	Nature clinical practice. Endocrinology & metabolism	2006	76
17478729	Fatty Acids, Nonesterified	Kim F	Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity.	Circulation research	2007	170
18777097	Fatty Acids, Nonesterified	Chang-Chen KJ	Beta-cell failure as a complication of diabetes.	Reviews in endocrine & metabolic disorders	2008	50
18956292	Fatty Acids, Nonesterified	Malhi H	Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease.	Seminars in liver disease	2008	141
19637289	Fatty Acids, Nonesterified	Johnson NA	Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.	Hepatology	2009	93
19780876	Fatty Acids, Nonesterified	Zheng L	Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD.	Journal of gastroenterology and hepatology	2010	41
21297467	Fatty Acids, Nonesterified	Boden G	Obesity, insulin resistance and free fatty acids.	Current opinion in endocrinology, diabetes, and obesity	2011	141
21663979	Fatty Acids, Nonesterified	Talukdar S	Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases.	Trends in pharmacological sciences	2011	57
21841783	Fatty Acids, Nonesterified	Ohtsubo K	Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport.	Nature medicine	2011	39
22041134	Fatty Acids, Nonesterified	Shearer GC	Fish oil -- how does it reduce plasma triglycerides?	Biochimica et biophysica acta	2012	38
22360800	Fatty Acids, Nonesterified	Martins AR	Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function.	Lipids in health and disease	2012	46
22429824	Fatty Acids, Nonesterified	de Heredia FP	Obesity, inflammation and the immune system.	The Proceedings of the Nutrition Society	2012	59
23577240	Fatty Acids, Nonesterified	Patel PS	The role of the immune system in obesity and insulin resistance.	Journal of obesity	2013	29
23666091	Fatty Acids, Nonesterified	Gaggini M	Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease.	Nutrients	2013	86
23855299	Fatty Acids, Nonesterified	Schuppan D	Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.	Journal of gastroenterology and hepatology	2013	56
24317117	Fatty Acids, Nonesterified	Clement LC	Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome.	Nature medicine	2014	30
24529130	Fatty Acids, Nonesterified	Alexopoulos N	Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis.	Atherosclerosis	2014	36
24577718	Fatty Acids, Nonesterified	Nielsen TS	Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease.	Journal of molecular endocrinology	2014	34
26628415	Fatty Acids, Nonesterified	Henson J	Breaking Up Prolonged Sitting With Standing or Walking Attenuates the Postprandial Metabolic Response in Postmenopausal Women: A Randomized Acute Study.	Diabetes care	2016	21
26650570	Fatty Acids, Nonesterified	Wilson CG	Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.	Endocrinology	2016	17
26780287	Fatty Acids, Nonesterified	Luukkonen PK	Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.	Journal of hepatology	2016	20
27863537	Fatty Acids, Nonesterified	Haraszti RA	High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.	Journal of extracellular vesicles	2016	21
28219080	Fatty Acids, Nonesterified	Pan Y	Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism.	Nature	2017	20
19380441	Platinum	Yuan X	Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.	Journal of clinical oncology 	2009	59
20547991	Platinum	Konstantinopoulos PA	Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.	Journal of clinical oncology 	2010	112
23401448	Platinum	Mok T	Treating patients with EGFR-sensitizing mutations: first line or second line--is there a difference?	Journal of clinical oncology 	2013	30
24958820	Platinum	Fakhry C	Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.	Journal of clinical oncology 	2014	44
25091798	Platinum	Masterson L	De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials.	European journal of cancer	2014	39
25349291	Platinum	Iyengar P	Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.	Journal of clinical oncology 	2014	35
25708226	Platinum	Tangutoori S	PARP inhibitors: A new era of targeted therapy.	Maturitas	2015	29
26463832	Platinum	Konstantinopoulos PA	Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer.	Cancer discovery	2015	39
27590317	Platinum	Mateo J	DNA Repair in Prostate Cancer: Biology and Clinical Implications.	European urology	2017	7
28373005	Platinum	Gulley JL	Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial.	The Lancet. Oncology	2017	23
10974057	Hydrogen Peroxide	Navab M	Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.	Journal of lipid research	2000	98
22375014	Hydrogen Peroxide	Murai J	Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells.	The Journal of biological chemistry	2012	41
24528134	Hydrogen Peroxide	Bekeschus S	Hydrogen peroxide: A central player in physical plasma-induced oxidative stress in human blood cells.	Free radical research	2014	30
25617667	Hydrogen Peroxide	Slominski AT	Novel non-calcemic secosteroids that are produced by human epidermal keratinocytes protect against solar radiation.	The Journal of steroid biochemistry and molecular biology	2015	20
27833040	Hydrogen Peroxide	Doskey CM	Tumor cells have decreased ability to metabolize H2O2: Implications for pharmacological ascorbate in cancer therapy.	Redox biology	2016	13
1473146	Glutathione	Devary Y	The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases.	Cell	1992	133
10385608	Glutathione	Lu SC	Regulation of hepatic glutathione synthesis: current concepts and controversies.	FASEB journal 	1999	121
11563810	Glutathione	Whitfield JB	Gamma glutamyl transferase.	Critical reviews in clinical laboratory sciences	2001	138
12946237	Glutathione	Kidd P	Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.	Alternative medicine review 	2003	164
18267127	Glutathione	Go YM	Redox compartmentalization in eukaryotic cells.	Biochimica et biophysica acta	2008	136
18572023	Glutathione	Pi J	Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2.	Free radical biology & medicine	2008	53
19074031	Glutathione	Vargas MR	Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis.	The Journal of neuroscience 	2008	131
25937369	Glutathione	Dannenmann B	High glutathione and glutathione peroxidase-2 levels mediate cell-type-specific DNA damage protection in human induced pluripotent stem cells.	Stem cell reports	2015	17
27477511	Glutathione	Chio IIC	NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer.	Cell	2016	29
15221504	Hydrogen Sulfide	Kamoun P	Endogenous production of hydrogen sulfide in mammals.	Amino acids	2004	80
15255956	Hydrogen Sulfide	Whiteman M	The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'?	Journal of neurochemistry	2004	125
17377202	Hydrogen Sulfide	Łowicka E	Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists.	Pharmacological reports 	2007	107
17629356	Hydrogen Sulfide	Qu K	Hydrogen sulfide: neurochemistry and neurobiology.	Neurochemistry international	2008	55
20061650	Hydrogen Sulfide	McGeer EG	Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy.	Journal of Alzheimer's disease 	2010	85
20636621	Hydrogen Sulfide	Tang G	Interaction of hydrogen sulfide with ion channels.	Clinical and experimental pharmacology & physiology	2010	48
22169477	Hydrogen Sulfide	Krishnan N	H2S-Induced sulfhydration of the phosphatase PTP1B and its role in the endoplasmic reticulum stress response.	Science signaling	2011	111
22535897	Hydrogen Sulfide	Wang R	Physiological implications of hydrogen sulfide: a whiff exploration that blossomed.	Physiological reviews	2012	270
23297346	Hydrogen Sulfide	Zhang Y	Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases.	Molecular and cellular biology	2013	27
25196086	Hydrogen Sulfide	Muniraj N	Hydrogen sulfide acts as a pro-inflammatory mediator in rheumatic disease.	International journal of rheumatic diseases	2017	7
26275994	Hydrogen Sulfide	Yang R	Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis.	Immunity	2015	29
11507175	Melatonin	Thapan K	An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans.	The Journal of physiology	2001	134
15845344	Melatonin	Iuvone PM	Circadian clocks, clock networks, arylalkylamine N-acetyltransferase, and melatonin in the retina.	Progress in retinal and eye research	2005	72
20463367	Melatonin	Gooley JJ	Spectral responses of the human circadian system depend on the irradiance and duration of exposure to light.	Science translational medicine	2010	54
21415172	Melatonin	Cajochen C	Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance.	Journal of applied physiology	2011	48
24449876	Melatonin	Archer SN	Mistimed sleep disrupts circadian regulation of the human transcriptome.	Proceedings of the National Academy of Sciences of the United States of America	2014	53
24914052	Melatonin	deHaro D	Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night.	Nucleic acids research	2014	22
26359987	Melatonin	Farez MF	Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses.	Cell	2015	31
15933054	Bleomycin	Farinha P	Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).	Blood	2005	85
17923702	Bleomycin	Sun Y	DNA damage-induced acetylation of lysine 3016 of ATM activates ATM kinase activity.	Molecular and cellular biology	2007	106
22487937	Bleomycin	Özgür E	Differential expression of long non-coding RNAs during genotoxic stress-induced apoptosis in HeLa and MCF-7 cells.	Clinical and experimental medicine	2013	25
11146650	Etoposide	Tsukamoto T	Visualization of gene activity in living cells.	Nature cell biology	2000	96
12670868	Etoposide	Wysocka J	Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1.	Genes & development	2003	172
12826401	Etoposide	Wysocka J	The herpes simplex virus VP16-induced complex: the makings of a regulatory switch.	Trends in biochemical sciences	2003	121
20351298	Etoposide	de Feraudy S	A minority of foci or pan-nuclear apoptotic staining of gammaH2AX in the S phase after UV damage contain DNA double-strand breaks.	Proceedings of the National Academy of Sciences of the United States of America	2010	63
21087997	Etoposide	Quennet V	CtIP and MRN promote non-homologous end-joining of etoposide-induced DNA double-strand breaks in G1.	Nucleic acids research	2011	35
21217779	Etoposide	Ogiwara H	Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI/SNF chromatin remodeling and the recruitment of non-homologous end joining factors.	Oncogene	2011	93
22615413	Etoposide	Cowell IG	Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity.	Proceedings of the National Academy of Sciences of the United States of America	2012	37
20238327	irinotecan	Wagner AD	Chemotherapy for advanced gastric cancer.	The Cochrane database of systematic reviews	2010	148
22228631	irinotecan	Spindler KL	Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan.	Clinical cancer research 	2012	52
23649448	irinotecan	Jett JR	Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.	Chest	2013	45
15342805	Tamoxifen	Hughes KS	Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer.	The New England journal of medicine	2004	106
15632378	Tamoxifen	Jin Y	CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.	Journal of the National Cancer Institute	2005	181
16361630	Tamoxifen	Goetz MP	Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.	Journal of clinical oncology 	2005	166
18765548	Tamoxifen	Helleman J	Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response.	Clinical cancer research 	2008	58
20224296	Tamoxifen	Dalby KN	Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer.	Autophagy	2010	135
21922245	Tamoxifen	Livaudais JC	Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer.	Breast cancer research and treatment	2012	30
23690420	Tamoxifen	Hughes KS	Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.	Journal of clinical oncology 	2013	77
24186067	Tamoxifen	Lemke G	Biology of the TAM receptors.	Cold Spring Harbor perspectives in biology	2013	70
25939896	Tamoxifen	Coates AS	Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.	Annals of oncology 	2015	194
26092816	Tamoxifen	Bernhard J	Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.	The Lancet. Oncology	2015	21
9741580	Nitric Oxide	Wink DA	Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide.	Free radical biology & medicine	1998	161
10194201	Nitric Oxide	Kellogg DL Jr	Role of nitric oxide in the vascular effects of local warming of the skin in humans.	Journal of applied physiology	1999	111
11568143	Nitric Oxide	Minson CT	Nitric oxide and neurally mediated regulation of skin blood flow during local heating.	Journal of applied physiology	2001	153
11698024	Nitric Oxide	Zimmermann M	Pathobiology of neuropathic pain.	European journal of pharmacology	2001	137
15178764	Nitric Oxide	Thomas DD	Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide.	Proceedings of the National Academy of Sciences of the United States of America	2004	90
15690474	Nitric Oxide	Sirica AE	Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy.	Hepatology	2005	98
15889141	Nitric Oxide	Hui J	Intronic CA-repeat and CA-rich elements: a new class of regulators of mammalian alternative splicing.	The EMBO journal	2005	83
16818701	Nitric Oxide	Pantuck AJ	Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.	Clinical cancer research 	2006	70
17273169	Nitric Oxide	Leiper J	Disruption of methylarginine metabolism impairs vascular homeostasis.	Nature medicine	2007	97
18644187	Nitric Oxide	Hei TK	Mechanism of radiation-induced bystander effects: a unifying model.	The Journal of pharmacy and pharmacology	2008	77
19194382	Nitric Oxide	Isenberg JS	Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies.	Nature reviews. Cancer	2009	93
19488045	Nitric Oxide	Rao JS	Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients.	Molecular psychiatry	2010	89
19789382	Nitric Oxide	Vollmar B	The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair.	Physiological reviews	2009	72
21233414	Nitric Oxide	Wink DA	Nitric oxide and redox mechanisms in the immune response.	Journal of leukocyte biology	2011	115
21544630	Nitric Oxide	Singh S	Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies.	Cancer chemotherapy and pharmacology	2011	39
21686173	Nitric Oxide	Fernández-Sánchez A	Inflammation, oxidative stress, and obesity.	International journal of molecular sciences	2011	117
21876168	Nitric Oxide	Song JW	Fluid forces control endothelial sprouting.	Proceedings of the National Academy of Sciences of the United States of America	2011	104
22144946	Nitric Oxide	Karar J	PI3K/AKT/mTOR Pathway in Angiogenesis.	Frontiers in molecular neuroscience	2011	131
22484314	Nitric Oxide	Mazzuca MQ	Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease.	Biochemical pharmacology	2012	31
22553494	Nitric Oxide	Lawler PR	Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.	Cold Spring Harbor perspectives in medicine	2012	88
22878588	Nitric Oxide	Switzer CH	S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer.	Molecular cancer research 	2012	31
23271799	Nitric Oxide	Ridnour LA	Molecular pathways: toll-like receptors in the tumor microenvironment--poor prognosis or new therapeutic opportunity.	Clinical cancer research 	2013	35
23354310	Nitric Oxide	Burke AJ	The yin and yang of nitric oxide in cancer progression.	Carcinogenesis	2013	39
23859953	Nitric Oxide	Rochette L	Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?	Pharmacology & therapeutics	2013	46
24024171	Nitric Oxide	Cantu-Medellin N	Xanthine oxidoreductase-catalyzed reactive species generation: A process in critical need of reevaluation.	Redox biology	2013	28
24733928	Nitric Oxide	Heinecke JL	Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.	Proceedings of the National Academy of Sciences of the United States of America	2014	34
26586908	Nitric Oxide	Fujii N	iNOS-dependent sweating and eNOS-dependent cutaneous vasodilation are evident in younger adults, but are diminished in older adults exercising in the heat.	Journal of applied physiology	2016	10
11740489	Oligonucleotides, Antisense	Hofmann TG	Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2.	Nature cell biology	2002	156
18371932	Oligonucleotides, Antisense	Hua Y	Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice.	American journal of human genetics	2008	144
18429962	Oligonucleotides, Antisense	Takakura S	Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.	Cancer science	2008	72
20624852	Oligonucleotides, Antisense	Hua Y	Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model.	Genes & development	2010	142
21028906	Oligonucleotides, Antisense	Gagnon KT	Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.	Biochemistry	2010	46
21979052	Oligonucleotides, Antisense	Hua Y	Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.	Nature	2011	194
21979053	Oligonucleotides, Antisense	Taniguchi-Ikeda M	Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy.	Nature	2011	43
22333591	Oligonucleotides, Antisense	Cirera-Salinas D	Mir-33 regulates cell proliferation and cell cycle progression.	Cell cycle	2012	56
23963702	Oligonucleotides, Antisense	Østergaard ME	Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS.	Nucleic acids research	2013	35
24861627	Oligonucleotides, Antisense	Liang XH	TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells.	Nucleic acids research	2014	22
26338776	Oligonucleotides, Antisense	Kamola PJ	In silico and in vitro evaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimization.	Nucleic acids research	2015	16
26578588	Oligonucleotides, Antisense	Lennox KA	Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides.	Nucleic acids research	2016	37
7671310	Phosphatidylinositols	Greenwell PW	TEL1, a gene involved in controlling telomere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene.	Cell	1995	141
7792600	Phosphatidylinositols	Savitsky K	A single ataxia telangiectasia gene with a product similar to PI-3 kinase.	Science	1995	485
9843217	Phosphatidylinositols	Khanna KK	ATM associates with and phosphorylates p53: mapping the region of interaction.	Nature genetics	1998	125
10608806	Phosphatidylinositols	Kim ST	Substrate specificities and identification of putative substrates of ATM kinase family members.	The Journal of biological chemistry	1999	223
10801416	Phosphatidylinositols	de Klein A	Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice.	Current biology 	2000	130
10839544	Phosphatidylinositols	Zhao S	Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products.	Nature	2000	109
15143086	Phosphatidylinositols	Chakravarti A	The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas.	Journal of clinical oncology 	2004	91
15613447	Phosphatidylinositols	Kwabi-Addo B	The role of fibroblast growth factors and their receptors in prostate cancer.	Endocrine-related cancer	2004	81
17124492	Phosphatidylinositols	Stiff T	ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling.	The EMBO journal	2006	135
17312392	Phosphatidylinositols	Hurley PJ	ATM and ATR: components of an integrated circuit.	Cell cycle	2007	61
18160036	Phosphatidylinositols	Takai H	Tel2 regulates the stability of PI3K-related protein kinases.	Cell	2007	80
18308254	Phosphatidylinositols	Bussink J	Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer.	The Lancet. Oncology	2008	84
18644989	Phosphatidylinositols	Toulany M	Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair.	Molecular cancer therapeutics	2008	52
19050071	Phosphatidylinositols	Sun Q	Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase.	Proceedings of the National Academy of Sciences of the United States of America	2008	187
23643389	Phosphatidylinositols	Hao Y	Gain of interaction with IRS1 by p110α-helical domain mutants is crucial for their oncogenic functions.	Cancer cell	2013	25
26233890	Phosphatidylinositols	Guo H	The PI3K/AKT Pathway and Renal Cell Carcinoma.	Journal of genetics and genomics = Yi chuan xue bao	2015	17
26253360	Phosphatidylinositols	Chang L	Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.	Critical reviews in oncology/hematology	2015	18
27481709	Phosphatidylinositols	Heldin CH	Signaling Receptors for TGF-β Family Members.	Cold Spring Harbor perspectives in biology	2016	14
16849518	Sirolimus	Koumenis C	"Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways.	Molecular cancer research 	2006	71
17047067	Sirolimus	Cao C	Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells.	Cancer research	2006	97
18276609	Sirolimus	Tang G	Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways.	Human molecular genetics	2008	53
18356598	Sirolimus	Zhou D	Human immunodeficiency virus type-1 infection inhibits autophagy.	AIDS	2008	66
19306412	Sirolimus	Amato RJ	A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer.	Cancer	2009	45
19773376	Sirolimus	Kim KW	Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model.	Clinical cancer research 	2009	47
22958932	Sirolimus	Iglesias-Bartolome R	mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis.	Cell stem cell	2012	91
23124837	Sirolimus	Hung CM	mTOR-dependent cell survival mechanisms.	Cold Spring Harbor perspectives in biology	2012	34
23155049	Sirolimus	Avrahami L	Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies.	The Journal of biological chemistry	2013	43
24270418	Sirolimus	Liu SC	Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance.	The Journal of clinical investigation	2013	29
24311635	Sirolimus	Kahn J	The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.	Neuro-oncology	2014	23
24445654	Sirolimus	Chang L	Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.	Cancer metastasis reviews	2014	21
24470531	Sirolimus	Farid M	Malignant peripheral nerve sheath tumors.	The oncologist	2014	23
24954509	Sirolimus	Chou SD	HSF1 regulation of β-catenin in mammary cancer cells through control of HuR/elavL1 expression.	Oncogene	2015	21
25532816	Sirolimus	Simpson DR	Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck.	Oral oncology	2015	21
26134657	Sirolimus	Du K	Pten Deletion Promotes Regrowth of Corticospinal Tract Axons 1 Year after Spinal Cord Injury.	The Journal of neuroscience 	2015	21
26565512	Sirolimus	Qiang L	Autophagy positively regulates DNA damage recognition by nucleotide excision repair.	Autophagy	2016	12
27465917	Sirolimus	Mao Y	IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.	Blood	2016	16
27597759	Sirolimus	Sargent G	PEX2 is the E3 ubiquitin ligase required for pexophagy during starvation.	The Journal of cell biology	2016	13
28292440	Sirolimus	Fan Q	A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma.	Cancer cell	2017	7
11591849	Superoxides	Alexianu ME	Immune reactivity in a mouse model of familial ALS correlates with disease progression.	Neurology	2001	95
14734542	Superoxides	Rakhit R	Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis.	The Journal of biological chemistry	2004	93
16885361	Superoxides	Slane BG	Mutation of succinate dehydrogenase subunit C results in increased O2.-, oxidative stress, and genomic instability.	Cancer research	2006	62
18160659	Superoxides	Chen XJ	Proprioceptive sensory neuropathy in mice with a mutation in the cytoplasmic Dynein heavy chain 1 gene.	The Journal of neuroscience 	2007	60
18781224	Superoxides	Jacobs KM	SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression.	International journal of biological sciences	2008	74
20428114	Superoxides	Maruyama H	Mutations of optineurin in amyotrophic lateral sclerosis.	Nature	2010	259
23000343	Superoxides	Li L	Starvation-induced autophagy is regulated by mitochondrial reactive oxygen species leading to AMPK activation.	Cellular signalling	2013	59
23660296	Superoxides	Chatterton DE	Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns.	The international journal of biochemistry & cell biology	2013	44
27001847	Superoxides	Zhang C	Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.	Proceedings of the National Academy of Sciences of the United States of America	2016	42
1933891	Caffeine	Kastan MB	Participation of p53 protein in the cellular response to DNA damage.	Cancer research	1991	637
10485486	Caffeine	Sarkaria JN	Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.	Cancer research	1999	309
11535615	Caffeine	Feijoo C	Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing.	The Journal of cell biology	2001	121
12446774	Caffeine	Heffernan TP	An ATR- and Chk1-dependent S checkpoint inhibits replicon initiation following UVC-induced DNA damage.	Molecular and cellular biology	2002	91
19502790	Caffeine	Gupta A	Cell cycle checkpoint defects contribute to genomic instability in PTEN deficient cells independent of DNA DSB repair.	Cell cycle	2009	46
23929677	Caffeine	Sinha RA	Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.	Hepatology	2014	48
1473734	Antioxidants	Schreck R	Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review).	Free radical research communications	1992	186
7649494	Antioxidants	Packer L	alpha-Lipoic acid as a biological antioxidant.	Free radical biology & medicine	1995	171
9989453	Antioxidants	Smith KJ	Demyelination: the role of reactive oxygen and nitrogen species.	Brain pathology	1999	98
10863535	Antioxidants	Gutteridge JM	Free radicals and antioxidants in the year 2000. A historical look to the future.	Annals of the New York Academy of Sciences	2000	109
12361782	Antioxidants	Fang YZ	Free radicals, antioxidants, and nutrition.	Nutrition	2002	181
12821280	Antioxidants	Ichihashi M	UV-induced skin damage.	Toxicology	2003	101
15909857	Antioxidants	Devasagayam TP	Free radicals and antioxidants in human health: current status and future prospects.	The Journal of the Association of Physicians of India	2004	177
17326724	Antioxidants	van der Pluijm I	Impaired genome maintenance suppresses the growth hormone--insulin-like growth factor 1 axis in mice with Cockayne syndrome.	PLoS biology	2007	84
17671740	Antioxidants	Kohjima M	Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.	International journal of molecular medicine	2007	76
18588875	Antioxidants	Brennan LA	Mitochondrial function and redox control in the aging eye: role of MsrA and other repair systems in cataract and macular degenerations.	Experimental eye research	2009	45
20716925	Antioxidants	Acharya A	Redox regulation in cancer: a double-edged sword with therapeutic potential.	Oxidative medicine and cellular longevity	2010	104
20969478	Antioxidants	Tang D	High-mobility group box 1, oxidative stress, and disease.	Antioxidants & redox signaling	2011	108
21453242	Antioxidants	Buettner GR	Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide.	Anti-cancer agents in medicinal chemistry	2011	41
21605374	Antioxidants	Sotgia F	Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention?	BMC medicine	2011	36
21616142	Antioxidants	Batinic-Haberle I	Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.	Free radical biology & medicine	2011	50
21670343	Antioxidants	Ho L	Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and ω-3 fatty acids: the Rotterdam study.	Archives of ophthalmology	2011	40
22226887	Antioxidants	Galli F	Oxidative stress and antioxidant therapy in cystic fibrosis.	Biochimica et biophysica acta	2012	33
22271002	Antioxidants	Maes M	New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.	Inflammopharmacology	2012	41
22739839	Antioxidants	Pandi-Perumal SR	Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.	Neurotoxicity research	2013	33
23303309	Antioxidants	Watson J	Oxidants, antioxidants and the current incurability of metastatic cancers.	Open biology	2013	86
23393548	Antioxidants	Wen YD	Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress.	PloS one	2013	38
23434765	Antioxidants	Niture SK	Regulation of Nrf2-an update.	Free radical biology & medicine	2014	105
23702245	Antioxidants	Dodson M	Cellular metabolic and autophagic pathways: traffic control by redox signaling.	Free radical biology & medicine	2013	81
24630991	Antioxidants	Edwards MR	The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway.	Cell reports	2014	29
24969860	Antioxidants	Gupta RK	Oxidative stress and antioxidants in disease and cancer: a review.	Asian Pacific journal of cancer prevention 	2014	32
26691854	Antioxidants	Zhao Q	Downregulation of Nrf2 promotes radiation-induced apoptosis through Nrf2 mediated Notch signaling in non-small cell lung cancer cells.	International journal of oncology	2016	12
26706242	Antioxidants	Peh HY	Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol.	Pharmacology & therapeutics	2016	11
27225690	Antioxidants	Gerber PA	The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus.	Antioxidants & redox signaling	2017	7
28007895	Antioxidants	Semenza GL	Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype.	The EMBO journal	2017	12
15897578	gemcitabine	Berberat PO	Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment.	Clinical cancer research 	2005	67
16034041	gemcitabine	von der Maase H	Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.	Journal of clinical oncology 	2005	228
18245495	gemcitabine	Hwang RF	Cancer-associated stromal fibroblasts promote pancreatic tumor progression.	Cancer research	2008	289
18509182	gemcitabine	Brunner TB	Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.	Journal of clinical oncology 	2008	51
18698032	gemcitabine	Morgan MA	The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer.	Clinical cancer research 	2008	56
20501833	gemcitabine	Morgan MA	Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.	Cancer research	2010	100
21081113	gemcitabine	Kikuta K	Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells.	Biochemical and biophysical research communications	2010	54
21489257	gemcitabine	Lister A	Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy.	Molecular cancer	2011	52
21969517	gemcitabine	Von Hoff DD	Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.	Journal of clinical oncology 	2011	260
22510406	gemcitabine	Hamada S	Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells.	Biochemical and biophysical research communications	2012	46
22825331	gemcitabine	Prevo R	The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.	Cancer biology & therapy	2012	57
23222511	gemcitabine	Fokas E	Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.	Cell death & disease	2012	57
23341531	gemcitabine	Herman JM	Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results.	Journal of clinical oncology 	2013	36
24220555	gemcitabine	Poplin E	Randomized, multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma: including a prospective evaluation of the role of hENT1 in gemcitabine or CO-101 sensitivity.	Journal of clinical oncology 	2013	39
24562449	gemcitabine	Sinn M	SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study.	Annals of oncology 	2014	24
25453096	gemcitabine	Samanta D	Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2014	69
25832687	gemcitabine	Tan T	Concurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma.	International journal of radiation oncology, biology, physics	2015	35
26169969	gemcitabine	Hidalgo M	SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial.	Clinical cancer research 	2015	30
26517239	gemcitabine	Vendetti FP	The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.	Oncotarget	2015	26
26862857	gemcitabine	Khan K	miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial.	Oncotarget	2016	11
27216178	gemcitabine	Schultz MJ	The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.	Cancer research	2016	12
27742686	gemcitabine	Ireland L	Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors.	Cancer research	2016	16
15685439	O-(6)-methylguanine	Ohgaki H	Epidemiology and etiology of gliomas.	Acta neuropathologica	2005	228
18483356	O-(6)-methylguanine	Sarkaria JN	Mechanisms of chemoresistance to alkylating agents in malignant glioma.	Clinical cancer research 	2008	83
20150378	O-(6)-methylguanine	Rivera AL	MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma.	Neuro-oncology	2010	60
21292686	O-(6)-methylguanine	Kunz M	Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.	Neuro-oncology	2011	37
22261329	O-(6)-methylguanine	Roos WP	DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis.	Cancer letters	2013	153
23095825	O-(6)-methylguanine	Weller M	Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice.	Neuro-oncology	2012	31
25537990	O-(6)-methylguanine	Jansen NL	Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma.	Journal of nuclear medicine 	2015	16
8885242	Reactive Oxygen Species	Barcellos-Hoff MH	Redox-mediated activation of latent transforming growth factor-beta 1.	Molecular endocrinology	1996	132
9560228	Reactive Oxygen Species	Ramana CV	Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals.	Proceedings of the National Academy of Sciences of the United States of America	1998	100
9633809	Reactive Oxygen Species	Hall ED	Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.	Glia	1998	124
15297389	Reactive Oxygen Species	De Larco JE	The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8.	Clinical cancer research 	2004	72
17116235	Reactive Oxygen Species	Lambert MP	Monoclonal antibodies that target pathological assemblies of Abeta.	Journal of neurochemistry	2007	109
17179479	Reactive Oxygen Species	Phillips TM	The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.	Journal of the National Cancer Institute	2006	416
17704323	Reactive Oxygen Species	Zhao W	Oxidative damage pathways in relation to normal tissue injury.	The British journal of radiology	2007	56
18192505	Reactive Oxygen Species	Sallmyr A	Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML.	Blood	2008	79
18193822	Reactive Oxygen Species	Hoye AT	Targeting mitochondria.	Accounts of chemical research	2008	91
18245082	Reactive Oxygen Species	Devi L	Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.	The Journal of biological chemistry	2008	198
18413749	Reactive Oxygen Species	Derdak Z	The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells.	Cancer research	2008	56
19285945	Reactive Oxygen Species	Gandhi S	PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death.	Molecular cell	2009	170
19607894	Reactive Oxygen Species	Foldbjerg R	PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes.	Toxicology letters	2009	76
19706526	Reactive Oxygen Species	Bertout JA	HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses.	Proceedings of the National Academy of Sciences of the United States of America	2009	59
20179104	Reactive Oxygen Species	Mai S	Decreased expression of Drp1 and Fis1 mediates mitochondrial elongation in senescent cells and enhances resistance to oxidative stress through PINK1.	Journal of cell science	2010	49
21072054	Reactive Oxygen Species	Lee JJ	PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation.	Cell death and differentiation	2011	41
21232014	Reactive Oxygen Species	Wu S	Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins.	The FEBS journal	2011	82
21386137	Reactive Oxygen Species	Ozden O	Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative stress.	Aging	2011	55
21567162	Reactive Oxygen Species	Shao L	Reactive oxygen species and hematopoietic stem cell senescence.	International journal of hematology	2011	39
21878644	Reactive Oxygen Species	Achuthan S	Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species.	The Journal of biological chemistry	2011	47
22079466	Reactive Oxygen Species	Piao LS	CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma.	Cancer letters	2012	53
22090360	Reactive Oxygen Species	Skinner HD	TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.	Clinical cancer research 	2012	70
22331464	Reactive Oxygen Species	Ma J	PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function.	Molecular and cellular biology	2012	37
22366891	Reactive Oxygen Species	Honda F	The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils.	Nature immunology	2012	33
22496421	Reactive Oxygen Species	Freund A	Lamin B1 loss is a senescence-associated biomarker.	Molecular biology of the cell	2012	113
22705852	Reactive Oxygen Species	Verfaillie T	PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress.	Cell death and differentiation	2012	115
22836756	Reactive Oxygen Species	Zhang X	MicroRNA-21 modulates the levels of reactive oxygen species by targeting SOD3 and TNFα.	Cancer research	2012	42
23378588	Reactive Oxygen Species	Gasparre G	Relevance of mitochondrial genetics and metabolism in cancer development.	Cold Spring Harbor perspectives in biology	2013	30
23535601	Reactive Oxygen Species	Son J	Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.	Nature	2013	342
23546867	Reactive Oxygen Species	Kwon JE	Ionizing radiation-inducible microRNA miR-193a-3p induces apoptosis by directly targeting Mcl-1.	Apoptosis 	2013	29
23703322	Reactive Oxygen Species	Montero J	p53 regulates a non-apoptotic death induced by ROS.	Cell death and differentiation	2013	38
23841983	Reactive Oxygen Species	Yu E	Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans.	Circulation	2013	34
23954870	Reactive Oxygen Species	Zuo L	The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.	Gene	2013	40
24040957	Reactive Oxygen Species	Paik YH	Role of NADPH oxidases in liver fibrosis.	Antioxidants & redox signaling	2014	43
24121277	Reactive Oxygen Species	Venere M	Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells.	Cell death and differentiation	2014	37
24293652	Reactive Oxygen Species	Lan L	Novel method for site-specific induction of oxidative DNA damage reveals differences in recruitment of repair proteins to heterochromatin and euchromatin.	Nucleic acids research	2014	25
24300855	Reactive Oxygen Species	Kim YW	Oxidative stress in angiogenesis and vascular disease.	Blood	2014	54
24692350	Reactive Oxygen Species	Bhattacharyya A	Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases.	Physiological reviews	2014	99
24791940	Reactive Oxygen Species	Cortez MA	Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer.	Molecular therapy 	2014	38
26344566	Reactive Oxygen Species	Zhang J	ATM functions at the peroxisome to induce pexophagy in response to ROS.	Nature cell biology	2015	45
26621844	Reactive Oxygen Species	Um HD	Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species.	Oncotarget	2016	22
26934227	Reactive Oxygen Species	Ma C	NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.	Nature	2016	37
26959556	Reactive Oxygen Species	Lang A	MicroRNA-15b regulates mitochondrial ROS production and the senescence-associated secretory phenotype through sirtuin 4/SIRT4.	Aging	2016	13
26982722	Reactive Oxygen Species	Ravindran R	The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation.	Nature	2016	27
28061435	Reactive Oxygen Species	Cheng LB	miRNA-141 attenuates UV-induced oxidative stress via activating Keap1-Nrf2 signaling in human retinal pigment epithelium cells and retinal ganglion cells.	Oncotarget	2017	6
22057348	Photosensitizing Agents	Mitsunaga M	Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules.	Nature medicine	2011	139
1484317	Formaldehyde	Cattoretti G	Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.	The Journal of pathology	1992	164
1709656	Formaldehyde	Shi SR	Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.	The journal of histochemistry and cytochemistry 	1991	268
19430420	Formaldehyde	Zuo Z	Application of COLD-PCR for improved detection of KRAS mutations in clinical samples.	Modern pathology 	2009	49
19657699	Formaldehyde	Saigusa S	Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.	Annals of surgical oncology	2009	81
20233444	Formaldehyde	Fumagalli D	A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes.	BMC cancer	2010	52
20925915	Formaldehyde	Ellison G	A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples.	Journal of experimental & clinical cancer research 	2010	43
22665543	Formaldehyde	Vakiani E	Comparative genomic analysis of primary versus metastatic colorectal carcinomas.	Journal of clinical oncology 	2012	74
23144797	Formaldehyde	Perkins G	Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers.	PloS one	2012	34
23154548	Formaldehyde	Heist RS	FGFR1 amplification in squamous cell carcinoma of the lung.	Journal of thoracic oncology 	2012	41
23830491	Formaldehyde	Choi SY	MicroRNA expression profiles in placenta with severe preeclampsia using a PNA-based microarray.	Placenta	2013	30
23979959	Formaldehyde	Nikiforova MN	Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer.	The Journal of clinical endocrinology and metabolism	2013	58
25502898	Formaldehyde	Warrick JI	Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma.	Virchows Archiv 	2015	16
25712460	Formaldehyde	Chung CH	Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.	Annals of oncology 	2015	19
26358176	Formaldehyde	Dietel M	A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.	Cancer gene therapy	2015	28
26724257	Formaldehyde	Mehra R	Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer.	European urology	2016	18
26913631	Formaldehyde	Howitt BE	Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva.	JAMA oncology	2016	10
27208205	Formaldehyde	Park JY	Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene.	Journal of medical genetics	2016	25
28463396	Formaldehyde	Pollack SM	T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.	Cancer	2017	6
15671234	Cholecalciferol	Hollis BW	Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D.	The Journal of nutrition	2005	210
17259988	Cholecalciferol	Sigmundsdottir H	DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27.	Nature immunology	2007	162
18088161	Cholecalciferol	Cranney A	Effectiveness and safety of vitamin D in relation to bone health.	Evidence report/technology assessment	2007	113
19756672	Cholecalciferol	Muthusamy V	The UV response of the skin: a review of the MAPK, NFkappaB and TNFalpha signal transduction pathways.	Archives of dermatological research	2010	41
22498493	Cholecalciferol	Bristol ML	Dual functions of autophagy in the response of breast tumor cells to radiation: cytoprotective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitamin D 3.	Autophagy	2012	33
23869782	Cholecalciferol	Slominski AT	Cytochromes p450 and skin cancer: role of local endocrine pathways.	Anti-cancer agents in medicinal chemistry	2014	37
17344486	Dietary Fats	Corcoran MP	Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise.	The American journal of clinical nutrition	2007	62
17540190	Dietary Fats	Sacks HS	Human epicardial adipose tissue: a review.	American heart journal	2007	158
19158321	Dietary Fats	Iqbal J	Intestinal lipid absorption.	American journal of physiology. Endocrinology and metabolism	2009	109
21708823	Dietary Fats	Hallsworth K	Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss.	Gut	2011	64
26068959	Dietary Fats	Hooper L	Reduction in saturated fat intake for cardiovascular disease.	The Cochrane database of systematic reviews	2015	36
9267023	Hydroxyurea	Scully R	Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.	Cell	1997	222
10839545	Hydroxyurea	Wu X	ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response.	Nature	2000	100
10859164	Hydroxyurea	Liu Q	Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.	Genes & development	2000	525
10973490	Hydroxyurea	Matsuoka S	Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro.	Proceedings of the National Academy of Sciences of the United States of America	2000	232
11673449	Hydroxyurea	Ward IM	Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress.	The Journal of biological chemistry	2001	364
11877376	Hydroxyurea	Kim ST	Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage.	Genes & development	2002	141
12766152	Hydroxyurea	Chini CC	Human claspin is required for replication checkpoint control.	The Journal of biological chemistry	2003	81
14985486	Hydroxyurea	Gladwin MT	Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.	The New England journal of medicine	2004	281
16431910	Hydroxyurea	Myers JS	Rapid activation of ATR by ionizing radiation requires ATM and Mre11.	The Journal of biological chemistry	2006	109
18045533	Hydroxyurea	Yang YG	Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease.	Cell	2007	131
20188668	Hydroxyurea	Petermann E	Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair.	Molecular cell	2010	276
21646340	Hydroxyurea	Elvers I	UV stalled replication forks restart by re-priming in human fibroblasts.	Nucleic acids research	2011	45
9349813	Capsaicin	Caterina MJ	The capsaicin receptor: a heat-activated ion channel in the pain pathway.	Nature	1997	1583
10201375	Capsaicin	Caterina MJ	A capsaicin-receptor homologue with a high threshold for noxious heat.	Nature	1999	262
12060783	Capsaicin	Huang SM	An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors.	Proceedings of the National Academy of Sciences of the United States of America	2002	190
12077606	Capsaicin	Smith GD	TRPV3 is a temperature-sensitive vanilloid receptor-like protein.	Nature	2002	165
12654248	Capsaicin	Story GM	ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures.	Cell	2003	580
12764195	Capsaicin	Prescott ED	A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity.	Science	2003	153
15306801	Capsaicin	Voets T	The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels.	Nature	2004	257
15813989	Capsaicin	Moriyama T	Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins.	Molecular pain	2005	99
16319926	Capsaicin	Zhang X	NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels.	The EMBO journal	2005	187
17499848	Capsaicin	Latorre R	ThermoTRP channels as modular proteins with allosteric gating.	Cell calcium	2007	60
17596456	Capsaicin	Lukacs V	Dual regulation of TRPV1 by phosphoinositides.	The Journal of neuroscience 	2007	113
22412190	Capsaicin	Cui Y	Selective disruption of high sensitivity heat activation but not capsaicin activation of TRPV1 channels by pore turret mutations.	The Journal of general physiology	2012	36
23500195	Capsaicin	Brederson JD	Targeting TRP channels for pain relief.	European journal of pharmacology	2013	62
26625315	Capsaicin	Ramos-Torres Á	The pepper's natural ingredient capsaicin induces autophagy blockage in prostate cancer cells.	Oncotarget	2016	11
9766667	wortmannin	Sarkaria JN	Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.	Cancer research	1998	151
10959836	wortmannin	Paull TT	A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.	Current biology 	2000	569
11331310	wortmannin	Rappold I	Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways.	The Journal of cell biology	2001	142
12956959	wortmannin	Takai H	DNA damage foci at dysfunctional telomeres.	Current biology 	2003	438
16732316	wortmannin	Cheng JC	Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway.	Oncogene	2006	64
7892263	Methyl Methanesulfonate	Haaf T	Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes.	Proceedings of the National Academy of Sciences of the United States of America	1995	165
9108475	Methyl Methanesulfonate	Essers J	Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination.	Cell	1997	126
10097101	Methyl Methanesulfonate	Wang XW	GADD45 induction of a G2/M cell cycle checkpoint.	Proceedings of the National Academy of Sciences of the United States of America	1999	116
10426999	Methyl Methanesulfonate	Zhong Q	Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.	Science	1999	126
11598186	Methyl Methanesulfonate	Gasch AP	Genomic expression responses to DNA-damaging agents and the regulatory role of the yeast ATR homolog Mec1p.	Molecular biology of the cell	2001	209
12509526	Methyl Methanesulfonate	Garcia V	AtATM is essential for meiosis and the somatic response to DNA damage in plants.	The Plant cell	2003	80
15210853	Methyl Methanesulfonate	Wang D	Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition.	Molecular cancer therapeutics	2004	82
11283670	trichostatin A	Kim MS	Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes.	Nature medicine	2001	145
15337792	trichostatin A	Cosio BG	Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages.	The Journal of experimental medicine	2004	86
17392473	trichostatin A	Dompierre JP	Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation.	The Journal of neuroscience 	2007	194
18664505	trichostatin A	Peng DF	DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma.	Gut	2009	54
19700647	trichostatin A	Guo W	Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition.	American journal of physiology. Lung cellular and molecular physiology	2009	69
20100935	trichostatin A	Grabiec AM	Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue.	Journal of immunology	2010	45
21447001	trichostatin A	Agudelo M	Effects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA).	Alcoholism, clinical and experimental research	2011	36
22038994	trichostatin A	Landreville S	Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.	Clinical cancer research 	2012	66
22282464	trichostatin A	Heller G	Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers.	Clinical cancer research 	2012	57
26408027	trichostatin A	Cai D	Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis.	Arthritis research & therapy	2015	16
11239454	Mitomycin	Garcia-Higuera I	Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.	Molecular cell	2001	377
12086603	Mitomycin	Taniguchi T	Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.	Cell	2002	129
12239151	Mitomycin	Taniguchi T	S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51.	Blood	2002	177
15314022	Mitomycin	Andreassen PR	ATR couples FANCD2 monoubiquitination to the DNA-damage response.	Genes & development	2004	143
17273966	Mitomycin	Jaspers NG	First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure.	American journal of human genetics	2007	64
17296736	Mitomycin	Wang X	Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.	Molecular and cellular biology	2007	58
19088202	Mitomycin	Reid LJ	E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks.	Proceedings of the National Academy of Sciences of the United States of America	2008	55
20007324	Mitomycin	Liang Y	Stem-like cancer cells are inducible by increasing genomic instability in cancer cells.	The Journal of biological chemistry	2010	44
23388460	Mitomycin	Fu D	Recruitment of DNA polymerase eta by FANCD2 in the early response to DNA damage.	Cell cycle	2013	27
24357716	Mitomycin	Oliveira DV	Histone chaperone FACT regulates homologous recombination by chromatin remodeling through interaction with RNF20.	Journal of cell science	2014	20
24794430	Mitomycin	Unno J	FANCD2 binds CtIP and regulates DNA-end resection during DNA interstrand crosslink repair.	Cell reports	2014	30
28575658	Mitomycin	Inano S	RFWD3-Mediated Ubiquitination Promotes Timely Removal of Both RPA and RAD51 from DNA Damage Sites to Facilitate Homologous Recombination.	Molecular cell	2017	8
8065934	polyglutamine	Chamberlain NL	The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.	Nucleic acids research	1994	152
16832050	polyglutamine	Duennwald ML	Flanking sequences profoundly alter polyglutamine toxicity in yeast.	Proceedings of the National Academy of Sciences of the United States of America	2006	120
19710014	polyglutamine	Aiken CT	Phosphorylation of threonine 3: implications for Huntingtin aggregation and neurotoxicity.	The Journal of biological chemistry	2009	50
20159555	polyglutamine	Hageman J	A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation.	Molecular cell	2010	84
20843828	polyglutamine	Vos MJ	HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular chaperones.	Human molecular genetics	2010	47
21231916	polyglutamine	Hageman J	The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities.	The Biochemical journal	2011	48
21247881	polyglutamine	de Mezer M	Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference.	Nucleic acids research	2011	61
21795378	polyglutamine	Mykowska A	CAG repeats mimic CUG repeats in the misregulation of alternative splicing.	Nucleic acids research	2011	62
22113611	polyglutamine	Koch P	Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.	Nature	2011	80
17033037	Fluorodeoxyglucose F18	Khatcheressian JL	American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.	Journal of clinical oncology 	2006	122
23129741	Fluorodeoxyglucose F18	Khatcheressian JL	Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.	Journal of clinical oncology 	2013	92
24029656	Fluorodeoxyglucose F18	Tamura K	64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer.	Journal of nuclear medicine 	2013	37
24337604	Fluorodeoxyglucose F18	Mortimer JE	Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.	Journal of nuclear medicine 	2014	32
26189600	Fluorodeoxyglucose F18	Vosselman MJ	Low brown adipose tissue activity in endurance-trained compared with lean sedentary men.	International journal of obesity	2015	24
26834099	Fluorodeoxyglucose F18	Avril S	¹⁸F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer.	Journal of nuclear medicine 	2016	13
27688480	Fluorodeoxyglucose F18	Yip SS	Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non-Small Cell Lung Cancer.	Journal of nuclear medicine 	2017	9
17920184	docetaxel	Heidenreich A	EAU guidelines on prostate cancer.	European urology	2008	142
18645028	docetaxel	Meng Y	Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.	Molecular cancer therapeutics	2008	60
21315502	docetaxel	Mottet N	EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.	European urology	2011	107
21976132	docetaxel	Araujo JC	Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study.	Cancer	2012	54
22387005	docetaxel	Shien K	Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.	Lung cancer	2012	33
24321502	docetaxel	Heidenreich A	EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.	European urology	2014	203
24616308	docetaxel	Goldkorn A	Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.	Journal of clinical oncology 	2014	50
24740415	docetaxel	Chen WX	Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs.	PloS one	2014	62
24799465	docetaxel	Giordano SH	Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline.	Journal of clinical oncology 	2014	52
24806399	docetaxel	Sonpavde G	Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer.	Clinical genitourinary cancer	2014	22
25002723	docetaxel	Harari PM	Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.	Journal of clinical oncology 	2014	22
25691773	docetaxel	de Leeuw R	Novel actions of next-generation taxanes benefit advanced stages of prostate cancer.	Clinical cancer research 	2015	22
27506431	docetaxel	Yadav MP	177Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment.	European journal of nuclear medicine and molecular imaging	2017	9
27591931	docetaxel	Cornford P	EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.	European urology	2017	44
8114714	Camptothecin	Nelson WG	DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.	Molecular and cellular biology	1994	152
12660252	Camptothecin	Furuta T	Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes.	The Journal of biological chemistry	2003	127
12676925	Camptothecin	Xiao Z	Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.	The Journal of biological chemistry	2003	81
17562789	Camptothecin	Suraweera A	Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage.	The Journal of cell biology	2007	57
19423727	Camptothecin	Singh TR	Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M.	Blood	2009	62
21693595	Camptothecin	Wang Y	MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression.	Molecular cancer research 	2011	46
22983061	Camptothecin	Oplustilova L	Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment.	Cell cycle	2012	46
23512991	Camptothecin	Batey MA	Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer.	Molecular cancer therapeutics	2013	32
1383826	Amyloid beta-Peptides	Haass C	Amyloid beta-peptide is produced by cultured cells during normal metabolism.	Nature	1992	281
8577726	Amyloid beta-Peptides	Lomakin A	On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants.	Proceedings of the National Academy of Sciences of the United States of America	1996	165
8621479	Amyloid beta-Peptides	Tjernberg LO	Arrest of beta-amyloid fibril formation by a pentapeptide ligand.	The Journal of biological chemistry	1996	131
9268388	Amyloid beta-Peptides	Walsh DM	Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.	The Journal of biological chemistry	1997	220
12815044	Amyloid beta-Peptides	Der-Sarkissian A	Structural organization of alpha-synuclein fibrils studied by site-directed spin labeling.	The Journal of biological chemistry	2003	97
15037694	Amyloid beta-Peptides	Ingelsson M	Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain.	Neurology	2004	181
16469784	Amyloid beta-Peptides	Townsend M	Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers.	The Journal of physiology	2006	180
22902550	Ursodeoxycholic Acid	Castro RE	miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.	Journal of hepatology	2013	59
25042122	Ursodeoxycholic Acid	Wang L	CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis.	Hepatology	2015	24
25500425	Ursodeoxycholic Acid	Hirschfield GM	Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.	Gastroenterology	2015	62
25678132	Ursodeoxycholic Acid	Ghonem NS	Fibrates and cholestasis.	Hepatology	2015	17
27207975	Ursodeoxycholic Acid	Sabino J	Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.	Gut	2016	18
11997274	Fatty Acids, Omega-3	Marchioli R	Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.	Circulation	2002	171
16963244	Fatty Acids, Omega-3	Chalon S	Omega-3 fatty acids and monoamine neurotransmission.	Prostaglandins, leukotrienes, and essential fatty acids	2006	71
17045449	Fatty Acids, Omega-3	Simopoulos AP	Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases.	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie	2006	118
20558833	Fatty Acids, Omega-3	Simopoulos AP	Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk.	Experimental biology and medicine	2010	52
21118617	Fatty Acids, Omega-3	Ramsden CE	n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials.	The British journal of nutrition	2010	51
22591894	Fatty Acids, Omega-3	Delgado-Lista J	Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.	The British journal of nutrition	2012	57
22770766	Fatty Acids, Omega-3	Orr SK	n-3 Polyunsaturated fatty acids in animal models with neuroinflammation.	Prostaglandins, leukotrienes, and essential fatty acids	2013	25
22841917	Fatty Acids, Omega-3	Luchtman DW	Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies.	Neuropharmacology	2013	43
24144963	Fatty Acids, Omega-3	Lopes da Silva S	Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis.	Alzheimer's & dementia 	2014	33
23169517	collagen type I trimeric cross-linked peptide	Smith DC	Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.	Journal of clinical oncology 	2013	120
11893340	Menthol	Peier AM	A TRP channel that senses cold stimuli and menthol.	Cell	2002	477
15492228	Menthol	Brauchi S	Clues to understanding cold sensation: thermodynamics and electrophysiological analysis of the cold receptor TRPM8.	Proceedings of the National Academy of Sciences of the United States of America	2004	95
15852009	Menthol	Rohács T	PI(4,5)P2 regulates the activation and desensitization of TRPM8 channels through the TRP domain.	Nature neuroscience	2005	193
17293875	Menthol	Voets T	TRPM8 voltage sensor mutants reveal a mechanism for integrating thermal and chemical stimuli.	Nature chemical biology	2007	79
18815250	Menthol	Xiao B	Identification of transmembrane domain 5 as a critical molecular determinant of menthol sensitivity in mammalian TRPA1 channels.	The Journal of neuroscience 	2008	93
22025699	Menthol	Zimmermann K	Transient receptor potential cation channel, subfamily C, member 5 (TRPC5) is a cold-transducer in the peripheral nervous system.	Proceedings of the National Academy of Sciences of the United States of America	2011	43
24071625	Menthol	Chen J	Species differences and molecular determinant of TRPA1 cold sensitivity.	Nature communications	2013	41
10811911	decitabine	Ferguson AT	High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2000	111
11196646	decitabine	Soengas MS	Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.	Nature	2001	164
19308264	decitabine	Garzia L	MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma.	PloS one	2009	79
20124447	decitabine	Zhang P	Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.	Molecular cancer therapeutics	2010	112
12520530	1,25-dihydroxyvitamin D	Holick MF	Vitamin D: A millenium perspective.	Journal of cellular biochemistry	2003	207
16563471	1,25-dihydroxyvitamin D	Lips P	Vitamin D physiology.	Progress in biophysics and molecular biology	2006	173
17205962	1,25-dihydroxyvitamin D	Craver L	Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.	Nephrology, dialysis, transplantation 	2007	55
17372031	1,25-dihydroxyvitamin D	Forman JP	Plasma 25-hydroxyvitamin D levels and risk of incident hypertension.	Hypertension	2007	210
22249518	1,25-dihydroxyvitamin D	Quarles LD	Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism.	Nature reviews. Endocrinology	2012	50
23922354	1,25-dihydroxyvitamin D	Bouillon R	Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine.	The Journal of clinical endocrinology and metabolism	2013	42
11358816	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Brognard J	Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.	Cancer research	2001	209
15059890	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Stiff T	ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation.	Cancer research	2004	300
16168105	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Wu G	Somatic mutation and gain of copy number of PIK3CA in human breast cancer.	Breast cancer research 	2005	66
16849522	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Pore N	Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway.	Molecular cancer research 	2006	62
17513297	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Kao GD	Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation.	The Journal of biological chemistry	2007	60
19435898	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Mukherjee B	EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma.	Cancer research	2009	74
21555850	Radiation-Sensitizing Agents	Ni X	Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.	The Journal of clinical investigation	2011	59
21852385	Radiation-Sensitizing Agents	Wang M	EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks.	Cancer research	2011	37
12480795	Docosahexaenoic Acids	Simopoulos AP	Omega-3 fatty acids in inflammation and autoimmune diseases.	Journal of the American College of Nutrition	2002	201
14762183	Docosahexaenoic Acids	Freedman SD	Association of cystic fibrosis with abnormalities in fatty acid metabolism.	The New England journal of medicine	2004	77
17101822	Docosahexaenoic Acids	Schaefer EJ	Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.	Archives of neurology	2006	117
19244379	Docosahexaenoic Acids	Harris WS	Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids.	The Journal of nutrition	2009	54
19535655	Docosahexaenoic Acids	Fetterman JW Jr	Therapeutic potential of n-3 polyunsaturated fatty acids in disease.	American journal of health-system pharmacy 	2009	49
19660687	Docosahexaenoic Acids	Lavie CJ	Omega-3 polyunsaturated fatty acids and cardiovascular diseases.	Journal of the American College of Cardiology	2009	92
20434961	Docosahexaenoic Acids	Yurko-Mauro K	Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.	Alzheimer's & dementia 	2010	89
21045096	Docosahexaenoic Acids	Quinn JF	Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.	JAMA	2010	123
21762726	Docosahexaenoic Acids	Poudyal H	Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action.	Progress in lipid research	2011	46
22840421	Docosahexaenoic Acids	AREDS2 Research Group.	The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).	Ophthalmology	2012	42
23481688	Docosahexaenoic Acids	Hjorth E	Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers.	Journal of Alzheimer's disease 	2013	30
24345162	Docosahexaenoic Acids	Vandal M	Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.	Journal of neurochemistry	2014	22
24351702	Docosahexaenoic Acids	de Oliveira Otto MC	Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis.	Journal of the American Heart Association	2013	32
24505350	Docosahexaenoic Acids	Nobili V	Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease.	PloS one	2014	22
25841249	Docosahexaenoic Acids	Bhaswant M	Mechanisms of enhanced insulin secretion and sensitivity with n-3 unsaturated fatty acids.	The Journal of nutritional biochemistry	2015	17
28114437	Docosahexaenoic Acids	Yassine HN	Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.	JAMA neurology	2017	8
10914698	temozolomide	Friedman HS	Temozolomide and treatment of malignant glioma.	Clinical cancer research 	2000	128
14709739	temozolomide	Calabrese CR	Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361.	Journal of the National Cancer Institute	2004	108
15041700	temozolomide	Hegi ME	Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide.	Clinical cancer research 	2004	146
16405512	temozolomide	Hermisson M	O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.	Journal of neurochemistry	2006	70
17363489	temozolomide	Thomas HD	Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial.	Molecular cancer therapeutics	2007	64
17827463	temozolomide	Stupp R	Chemoradiotherapy in malignant glioma: standard of care and future directions.	Journal of clinical oncology 	2007	118
18445844	temozolomide	Brandes AA	MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.	Journal of clinical oncology 	2008	146
18565887	temozolomide	Murat A	Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.	Journal of clinical oncology 	2008	233
18952979	temozolomide	Kitange GJ	Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts.	Neuro-oncology	2009	47
18955445	temozolomide	Brown PD	Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.	Journal of clinical oncology 	2008	67
19075262	temozolomide	Prados MD	Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.	Journal of clinical oncology 	2009	97
19269895	temozolomide	Stupp R	Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.	The Lancet. Oncology	2009	1345
19960228	temozolomide	Peereboom DM	Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.	Journal of neuro-oncology	2010	59
20530668	temozolomide	McEllin B	PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors.	Cancer research	2010	81
20855119	temozolomide	Minniti G	Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.	Radiotherapy and oncology 	2010	40
21135282	temozolomide	Lai A	Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme.	Journal of clinical oncology 	2011	140
21242296	temozolomide	Wolf A	Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme.	The Journal of experimental medicine	2011	162
21317208	temozolomide	Prasad G	Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.	Neuro-oncology	2011	48
21339192	temozolomide	Cohen KJ	Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group.	Neuro-oncology	2011	55
21499132	temozolomide	Fadul CE	Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy.	Journal of immunotherapy	2011	54
21606416	temozolomide	de Groot JF	Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study.	Journal of clinical oncology 	2011	47
21737504	temozolomide	Grossman SA	Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.	Clinical cancer research 	2011	84
22035272	temozolomide	Narayana A	A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma.	Journal of neurosurgery	2012	39
22045118	temozolomide	Johnson DR	Glioblastoma survival in the United States before and during the temozolomide era.	Journal of neuro-oncology	2012	152
22156195	temozolomide	Agnihotri S	Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients.	The Journal of clinical investigation	2012	32
22984531	temozolomide	Safdie F	Fasting enhances the response of glioma to chemo- and radiotherapy.	PloS one	2012	33
23115158	temozolomide	Li S	Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation.	Neuro-oncology	2013	38
23183822	temozolomide	Asuthkar S	Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity.	Oncotarget	2012	49
23370117	temozolomide	Curtin NJ	Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.	Molecular aspects of medicine	2013	75
23792642	temozolomide	Comincini S	microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells.	Cancer biology & therapy	2013	32
23818228	temozolomide	Siebzehnrubl FA	The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance.	EMBO molecular medicine	2013	76
24101040	temozolomide	Gilbert MR	Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.	Journal of clinical oncology 	2013	119
24552318	temozolomide	Chinot OL	Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.	The New England journal of medicine	2014	358
24650937	temozolomide	Murai J	Rationale for poly(ADP-ribose) polymerase (PARP) inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibition.	The Journal of pharmacology and experimental therapeutics	2014	37
25135958	temozolomide	Bao ZS	RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.	Genome research	2014	41
25163906	temozolomide	Stupp R	Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.	The Lancet. Oncology	2014	126
25468223	temozolomide	Cohen AL	Glioma biology and molecular markers.	Cancer treatment and research	2015	30
25526733	temozolomide	Ma DJ	A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K.	Neuro-oncology	2015	18
25609063	temozolomide	Pokorny JL	The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma.	Clinical cancer research 	2015	16
26846818	temozolomide	Phillips AC	ABT-414, an Antibody-Drug Conjugate Targeting a Tumor-Selective EGFR Epitope.	Molecular cancer therapeutics	2016	15
27370396	temozolomide	Wick W	Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.	Neuro-oncology	2016	11
27440269	temozolomide	Lok BH	PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.	Clinical cancer research 	2017	13
27503138	temozolomide	Arita H	A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas.	Acta neuropathologica communications	2016	12
28233083	temozolomide	Ludwig K	Molecular markers in glioma.	Journal of neuro-oncology	2017	9
28296618	temozolomide	Perry JR	Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.	The New England journal of medicine	2017	20
15517885	resveratrol	Aggarwal BB	Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.	Anticancer research	2004	204
18835033	resveratrol	Wang RH	Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.	Cancer cell	2008	260
20181810	resveratrol	Bakker GC	An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach.	The American journal of clinical nutrition	2010	45
25869442	resveratrol	Ferguson LR	Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.	Seminars in cancer biology	2015	27
12217698	thioflavin T	Hoyer W	Dependence of alpha-synuclein aggregate morphology on solution conditions.	Journal of molecular biology	2002	100
22715097	thioflavin T	Ano Bom AP	Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer.	The Journal of biological chemistry	2012	44
22908252	thioflavin T	Yoshimura Y	Distinguishing crystal-like amyloid fibrils and glass-like amorphous aggregates from their kinetics of formation.	Proceedings of the National Academy of Sciences of the United States of America	2012	40
19165151	oxaliplatin	Panaretakis T	Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death.	The EMBO journal	2009	137
21438154	oxaliplatin	Descoeur J	Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors.	EMBO molecular medicine	2011	59
21606427	oxaliplatin	Aschele C	Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.	Journal of clinical oncology 	2011	133
21709185	oxaliplatin	Crane CH	Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.	Journal of clinical oncology 	2011	68
22226241	oxaliplatin	Heinemann V	Systemic treatment of advanced pancreatic cancer.	Cancer treatment reviews	2012	37
22811078	oxaliplatin	Wang L	First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma.	Cancer	2013	36
23045248	oxaliplatin	Gavin PG	Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value.	Clinical cancer research 	2012	60
23102520	oxaliplatin	Cervantes A	Current questions for the treatment of advanced gastric cancer.	Cancer treatment reviews	2013	35
24152956	oxaliplatin	Mahaseth H	Modified FOLFIRINOX regimen with improved safety and maintained efficacy in pancreatic adenocarcinoma.	Pancreas	2013	35
24440715	oxaliplatin	Minett MS	Pain without nociceptors? Nav1.7-independent pain mechanisms.	Cell reports	2014	32
24717919	oxaliplatin	Primrose J	Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial.	The Lancet. Oncology	2014	46
25918279	oxaliplatin	Heestand GM	Approach to patients with pancreatic cancer without detectable metastases.	Journal of clinical oncology 	2015	16
26189067	oxaliplatin	Rödel C	Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.	The Lancet. Oncology	2015	41
28094194	oxaliplatin	Hickish T	MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study.	The Lancet. Oncology	2017	6
16243823	Curcumin	Aggarwal BB	Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.	Clinical cancer research 	2005	105
17332326	Curcumin	Li M	Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway.	Cancer research	2007	70
18462866	Curcumin	Anand P	Curcumin and cancer: an "old-age" disease with an "age-old" solution.	Cancer letters	2008	158
20924967	Curcumin	Goel A	Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs.	Nutrition and cancer	2010	83
21299897	Curcumin	Wilken R	Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.	Molecular cancer	2011	111
22952749	Curcumin	Bao B	Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.	PloS one	2012	43
26703799	Curcumin	Suresh R	The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.	Advances in experimental medicine and biology	2016	14
11483711	anandamide	Vellani V	Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide.	The Journal of physiology	2001	136
14517174	anandamide	Ross RA	Anandamide and vanilloid TRPV1 receptors.	British journal of pharmacology	2003	103
14707014	anandamide	Nilius B	TRPV4 calcium entry channel: a paradigm for gating diversity.	American journal of physiology. Cell physiology	2004	94
15128293	anandamide	Van Der Stelt M	Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels.	European journal of biochemistry	2004	81
15354183	anandamide	Giuffrida A	Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms.	Neuropsychopharmacology 	2004	82
15615864	anandamide	Gavva NR	AMG 9810 (E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzob1,4 dioxin-6-yl)acrylamide, a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties.	The Journal of pharmacology and experimental therapeutics	2005	89
15764707	anandamide	Zhang N	A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1.	Proceedings of the National Academy of Sciences of the United States of America	2005	70
17224929	anandamide	Côté M	Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.	International journal of obesity	2007	71
17327359	anandamide	Bátkai S	Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury.	FASEB journal 	2007	78
19835908	anandamide	Everaerts W	The vanilloid transient receptor potential channel TRPV4: from structure to disease.	Progress in biophysics and molecular biology	2010	75
23127915	anandamide	Guindon J	Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.	Pharmacological research	2013	35
23512546	anandamide	Blankman JL	Chemical probes of endocannabinoid metabolism.	Pharmacological reviews	2013	82
11350913	Poly Adenosine Diphosphate Ribose	Sunwoo JB	Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.	Clinical cancer research 	2001	99
12748298	Poly Adenosine Diphosphate Ribose	Okano S	Spatial and temporal cellular responses to single-strand breaks in human cells.	Molecular and cellular biology	2003	113
15833866	Poly Adenosine Diphosphate Ribose	Chinnaiyan P	Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).	Cancer research	2005	89
18468963	Poly Adenosine Diphosphate Ribose	Woodhouse BC	Poly ADP-ribose polymerase-1: an international molecule of mystery.	DNA repair	2008	62
18603595	Poly Adenosine Diphosphate Ribose	Godon C	PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility.	Nucleic acids research	2008	65
19661379	Poly Adenosine Diphosphate Ribose	Ahel D	Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1.	Science	2009	189
19917246	Poly Adenosine Diphosphate Ribose	Stilmann M	A nuclear poly(ADP-ribose)-dependent signalosome confers DNA damage-induced IkappaB kinase activation.	Molecular cell	2009	75
20133863	Poly Adenosine Diphosphate Ribose	Hegan DC	Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130.	Proceedings of the National Academy of Sciences of the United States of America	2010	50
20823146	Poly Adenosine Diphosphate Ribose	Redon CE	Histone gammaH2AX and poly(ADP-ribose) as clinical pharmacodynamic biomarkers.	Clinical cancer research 	2010	84
20937877	Poly Adenosine Diphosphate Ribose	Chou DM	A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage.	Proceedings of the National Academy of Sciences of the United States of America	2010	188
21555554	Poly Adenosine Diphosphate Ribose	Krawczyk PM	Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition.	Proceedings of the National Academy of Sciences of the United States of America	2011	49
21821475	Poly Adenosine Diphosphate Ribose	Helleday T	The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings.	Molecular oncology	2011	141
22641215	Poly Adenosine Diphosphate Ribose	Tobin LA	Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.	Oncogene	2013	30
22941645	Poly Adenosine Diphosphate Ribose	Krietsch J	PARP activation regulates the RNA-binding protein NONO in the DNA damage response to DNA double-strand breaks.	Nucleic acids research	2012	47
23045548	Poly Adenosine Diphosphate Ribose	Pines A	PARP1 promotes nucleotide excision repair through DDB2 stabilization and recruitment of ALC1.	The Journal of cell biology	2012	51
23264744	Poly Adenosine Diphosphate Ribose	Smeenk G	Poly(ADP-ribosyl)ation links the chromatin remodeler SMARCA5/SNF2H to RNF168-dependent DNA damage signaling.	Journal of cell science	2013	35
23337117	Poly Adenosine Diphosphate Ribose	Grotsky DA	BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells.	The Journal of cell biology	2013	26
23744078	Poly Adenosine Diphosphate Ribose	Young LC	Kdm4b histone demethylase is a DNA damage response protein and confers a survival advantage following γ-irradiation.	The Journal of biological chemistry	2013	39
23833192	Poly Adenosine Diphosphate Ribose	Mastrocola AS	The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage.	The Journal of biological chemistry	2013	40
24049082	Poly Adenosine Diphosphate Ribose	Rulten SL	PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage.	Nucleic acids research	2014	30
24450632	Poly Adenosine Diphosphate Ribose	Curtin N	PARP inhibitors for anticancer therapy.	Biochemical Society transactions	2014	20
24778210	Poly Adenosine Diphosphate Ribose	Li X	Histone demethylase KDM5B is a key regulator of genome stability.	Proceedings of the National Academy of Sciences of the United States of America	2014	25
25547115	Poly Adenosine Diphosphate Ribose	Li N	Poly-ADP ribosylation of PTEN by tankyrases promotes PTEN degradation and tumor growth.	Genes & development	2015	16
26091341	Poly Adenosine Diphosphate Ribose	Feng FY	Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function.	Molecular cell	2015	32
28241136	Poly Adenosine Diphosphate Ribose	Drané P	TIRR regulates 53BP1 by masking its histone methyl-lysine binding function.	Nature	2017	7
28288110	Poly Adenosine Diphosphate Ribose	Davies H	HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.	Nature medicine	2017	10
11904416	8-hydroxyguanine	Hazra TK	Identification and characterization of a human DNA glycosylase for repair of modified bases in oxidatively damaged DNA.	Proceedings of the National Academy of Sciences of the United States of America	2002	172
17279544	8-hydroxyguanine	Nakabeppu Y	Oxidative damage in nucleic acids and Parkinson's disease.	Journal of neuroscience research	2007	63
23775797	8-hydroxyguanine	Guo J	Comet-FISH with strand-specific probes reveals transcription-coupled repair of 8-oxoGuanine in human cells.	Nucleic acids research	2013	30
23868064	8-hydroxyguanine	Cheng Y	Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress.	Cell death & disease	2013	39
17363594	Angiogenesis Inhibitors	Jain RK	Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model.	Cancer research	2007	142
18539962	Angiogenesis Inhibitors	Eyler CE	Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis.	Journal of clinical oncology 	2008	179
19483739	Angiogenesis Inhibitors	Jain RK	Biomarkers of response and resistance to antiangiogenic therapy.	Nature reviews. Clinical oncology	2009	169
19826401	Angiogenesis Inhibitors	Norden AD	Antiangiogenic therapies for high-grade glioma.	Nature reviews. Neurology	2009	70
23045683	Angiogenesis Inhibitors	Huang Y	Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy.	Proceedings of the National Academy of Sciences of the United States of America	2012	133
23440426	Angiogenesis Inhibitors	Huang Y	Vascular normalization as an emerging strategy to enhance cancer immunotherapy.	Cancer research	2013	91
23989717	Angiogenesis Inhibitors	Ky B	Emerging paradigms in cardiomyopathies associated with cancer therapies.	Circulation research	2013	35
17620607	aristolochic acid I	Grollman AP	Aristolochic acid and the etiology of endemic (Balkan) nephropathy.	Proceedings of the National Academy of Sciences of the United States of America	2007	100
22071594	aristolochic acid I	Jelaković B	Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid.	Kidney international	2012	35
22121226	aristolochic acid I	Sidorenko VS	Lack of recognition by global-genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam-DNA adducts.	Nucleic acids research	2012	32
22493262	aristolochic acid I	Chen CH	Aristolochic acid-associated urothelial cancer in Taiwan.	Proceedings of the National Academy of Sciences of the United States of America	2012	69
23238808	aristolochic acid I	Grollman AP	Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease.	Environmental and molecular mutagenesis	2013	30
10606224	tirapazamine	Brown JM	The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.	Cancer research	1999	111
16517406	tirapazamine	Papandreou I	HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption.	Cell metabolism	2006	501
16960145	vorinostat	Duvic M	Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL).	Blood	2007	228
17594194	vorinostat	Duvic M	Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma.	Expert opinion on investigational drugs	2007	78
17962618	vorinostat	Mann BS	FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma.	The oncologist	2007	260
18541724	vorinostat	Buglio D	Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines.	Blood	2008	59
18981013	vorinostat	Luu TH	A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study.	Clinical cancer research 	2008	64
19307505	vorinostat	Galanis E	Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study.	Journal of clinical oncology 	2009	89
19738609	vorinostat	Munster PN	Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker.	British journal of cancer	2009	46
19789319	vorinostat	Palmieri D	Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks.	Clinical cancer research 	2009	47
19966789	vorinostat	Hutt DM	Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.	Nature chemical biology	2010	97
20378407	vorinostat	Ree AH	Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study.	The Lancet. Oncology	2010	40
21454553	vorinostat	Cenik B	Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia.	The Journal of biological chemistry	2011	45
21559012	vorinostat	Munster PN	A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer.	British journal of cancer	2011	81
21653597	vorinostat	Singh MM	Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.	Neuro-oncology	2011	38
22585696	vorinostat	Garcia-Manero G	Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome.	Journal of clinical oncology 	2012	39
22711276	vorinostat	Zhao L	Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.	Circulation	2012	47
24319254	vorinostat	Tian Z	A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance.	Blood	2014	65
24636848	vorinostat	Reguart N	Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression.	Lung cancer	2014	21
24991835	vorinostat	Mahalingam D	Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors.	Autophagy	2014	68
25428224	vorinostat	Choi SW	Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans.	Blood	2015	17
28193631	vorinostat	Pipalia NH	Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells.	Journal of lipid research	2017	6
11156414	pimonidazole	Wykoff CC	Hypoxia-inducible expression of tumor-associated carbonic anhydrases.	Cancer research	2000	271
21569415	pimonidazole	Rademakers SE	Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.	BMC cancer	2011	46
7697716	JM 3100	Aboussekhra A	Mammalian DNA nucleotide excision repair reconstituted with purified protein components.	Cell	1995	203
12791985	JM 3100	Zou L	Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes.	Science	2003	919
17538175	JM 3100	Pelloski CE	Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.	Journal of clinical oncology 	2007	85
19255243	JM 3100	Kalatskaya I	AMD3100 is a CXCR7 ligand with allosteric agonist properties.	Molecular pharmacology	2009	86
20154705	JM 3100	Lee DH	A PP4 phosphatase complex dephosphorylates RPA2 to facilitate DNA repair via homologous recombination.	Nature structural & molecular biology	2010	41
20631066	JM 3100	Kozin SV	Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation.	Cancer research	2010	82
20670894	JM 3100	Huang M	The FANCM/FAAP24 complex is required for the DNA interstrand crosslink-induced checkpoint response.	Molecular cell	2010	49
22370645	JM 3100	Jung MJ	Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.	Oncogene	2013	54
22661229	JM 3100	Galanty Y	RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair.	Genes & development	2012	113
22661230	JM 3100	Yin Y	SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage.	Genes & development	2012	91
16024631	Proteasome Inhibitors	Fernández Y	Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.	Cancer research	2005	69
21247388	Proteasome Inhibitors	Chen D	Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.	Current cancer drug targets	2011	151
22057347	Proteasome Inhibitors	D'Arcy P	Inhibition of proteasome deubiquitinating activity as a new cancer therapy.	Nature medicine	2011	108
23151137	Proteasome Inhibitors	Zhao Y	Cullin-RING Ligases as attractive anti-cancer targets.	Current pharmaceutical design	2013	50
24029229	Proteasome Inhibitors	Leung-Hagesteijn C	Xbp1s-negative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma.	Cancer cell	2013	82
24912524	Proteasome Inhibitors	Liu N	A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases.	Scientific reports	2014	24
14638850	gefitinib	Rich JN	Phase II trial of gefitinib in recurrent glioblastoma.	Journal of clinical oncology 	2004	134
16540671	gefitinib	Pore N	EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms.	Cancer research	2006	67
18211286	gefitinib	Vazquez-Martin A	Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells.	Cell proliferation	2008	59
23830194	gefitinib	Brand TM	Nuclear EGFR as a molecular target in cancer.	Radiotherapy and oncology 	2013	45
24021541	gefitinib	Iuchi T	Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma.	Lung cancer	2013	38
24165158	gefitinib	Rho JK	MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activation.	Cancer research	2014	30
10581258	Alanine	Bulavin DV	Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation.	The EMBO journal	1999	142
11390642	Alanine	Zhao H	ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.	Molecular and cellular biology	2001	344
18931676	Alanine	Ishiai M	FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway.	Nature structural & molecular biology	2008	89
22768106	Alanine	Chou SD	mTOR is essential for the proteotoxic stress response, HSF1 activation and heat shock protein synthesis.	PloS one	2012	53
24462733	Alanine	El-Serag HB	A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.	Gastroenterology	2014	34
24681128	Alanine	Fontana RJ	Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.	Gastroenterology	2014	26
25267294	Alanine	Barton O	Polo-like kinase 3 regulates CtIP during DNA double-strand break repair in G1.	The Journal of cell biology	2014	20
26537685	Alanine	Nakashima M	Structural Insights into HIV-1 Vif-APOBEC3F Interaction.	Journal of virology	2016	21
26769963	Alanine	Chang YJ	The Glycine-Alanine Dipeptide Repeat from C9orf72 Hexanucleotide Expansions Forms Toxic Amyloids Possessing Cell-to-Cell Transmission Properties.	The Journal of biological chemistry	2016	12
27670892	Alanine	Masuishi T	Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison.	Clinical colorectal cancer	2017	9
27995906	Alanine	Kwo PY	ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.	The American journal of gastroenterology	2017	8
28576675	Alanine	Baselga J	Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.	The Lancet. Oncology	2017	10
10198631	BH 3	Puthalakath H	The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex.	Molecular cell	1999	231
14963330	BH 3	Chipuk JE	Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.	Science	2004	486
15901672	BH 3	Willis SN	Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.	Genes & development	2005	416
20023629	BH 3	Schwickart M	Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.	Nature	2010	209
23173842	BH 3	Thomas S	Targeting the Bcl-2 family for cancer therapy.	Expert opinion on therapeutic targets	2013	46
23545417	BH 3	Shamas-Din A	Mechanisms of action of Bcl-2 family proteins.	Cold Spring Harbor perspectives in biology	2013	79
28017613	BH 3	Sarosiek KA	Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics.	Cancer cell	2017	15
9030687	Amino Acids	Kaufman PD	Ultraviolet radiation sensitivity and reduction of telomeric silencing in Saccharomyces cerevisiae cells lacking chromatin assembly factor-I.	Genes & development	1997	164
9467011	Amino Acids	Marsh DJ	Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.	Human molecular genetics	1998	121
9560156	Amino Acids	Kitada T	Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.	Nature	1998	978
11441147	Amino Acids	Reick M	NPAS2: an analog of clock operative in the mammalian forebrain.	Science	2001	142
12483741	Amino Acids	Aksentijevich I	De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.	Arthritis and rheumatism	2002	143
12510195	Amino Acids	Hergovich A	Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.	Nature cell biology	2003	102
12714972	Amino Acids	Eriksson M	Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.	Nature	2003	476
12807959	Amino Acids	Jezewski PA	Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate.	Journal of medical genetics	2003	85
14671112	Amino Acids	Vongpunsawad S	Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model.	Journal of virology	2004	80
16482215	Amino Acids	Nishitani H	Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis.	The EMBO journal	2006	152
16973212	Amino Acids	Meijer AJ	Signalling and autophagy regulation in health, aging and disease.	Molecular aspects of medicine	2006	68
17002572	Amino Acids	Ellies DL	Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity.	Journal of bone and mineral research 	2006	103
17601340	Amino Acids	Pan F	Analysis of septins across kingdoms reveals orthology and new motifs.	BMC evolutionary biology	2007	84
18177508	Amino Acids	Yang YS	The reticulons: a family of proteins with diverse functions.	Genome biology	2007	56
18559588	Amino Acids	Jeong EG	Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers.	Clinical cancer research 	2008	59
19167434	Amino Acids	Chen N	Role and regulation of autophagy in cancer.	Biochimica et biophysica acta	2009	84
19322201	Amino Acids	Abdelmohsen K	Ubiquitin-mediated proteolysis of HuR by heat shock.	The EMBO journal	2009	51
19429692	Amino Acids	D'Ambrogio A	Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo.	Nucleic acids research	2009	69
19561087	Amino Acids	Kohli RM	A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.	The Journal of biological chemistry	2009	59
19648920	Amino Acids	Wu X	Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.	Nature genetics	2009	97
19907493	Amino Acids	Konopka G	Human-specific transcriptional regulation of CNS development genes by FOXP2.	Nature	2009	114
20159109	Amino Acids	Giannandrea M	Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly.	American journal of human genetics	2010	61
20218600	Amino Acids	Gautier A	Genetically encoded photocontrol of protein localization in mammalian cells.	Journal of the American Chemical Society	2010	49
20381137	Amino Acids	Sancak Y	Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids.	Cell	2010	653
20920668	Amino Acids	McLaughlin HM	Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy.	American journal of human genetics	2010	64
21051598	Amino Acids	International HIV Controllers Study.	The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.	Science	2010	444
21138990	Amino Acids	Wang X	mTORC1 signaling: what we still don't know.	Journal of molecular cell biology	2011	49
21292473	Amino Acids	Tischfield MA	Phenotypic spectrum of the tubulin-related disorders and functional implications of disease-causing mutations.	Current opinion in genetics & development	2011	64
21307646	Amino Acids	Chong ZZ	Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.	Oxidative medicine and cellular longevity	2010	56
21544209	Amino Acids	Huang KH	Progression to AIDS in South Africa is associated with both reverting and compensatory viral mutations.	PloS one	2011	36
21980282	Amino Acids	Gnanakaran S	Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections.	PLoS pathogens	2011	66
22101681	Amino Acids	Chen WJ	Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia.	Nature genetics	2011	74
22494803	Amino Acids	Al-Quadan T	Exploitation of evolutionarily conserved amoeba and mammalian processes by Legionella.	Trends in microbiology	2012	34
22496159	Amino Acids	Cheng S	Metabolite profiling identifies pathways associated with metabolic risk in humans.	Circulation	2012	116
22749019	Amino Acids	Efeyan A	Amino acids and mTORC1: from lysosomes to disease.	Trends in molecular medicine	2012	126
23630012	Amino Acids	Nemazanyy I	Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal disease.	EMBO molecular medicine	2013	29
23762245	Amino Acids	Jia X	Imputing amino acid polymorphisms in human leukocyte antigens.	PloS one	2013	132
24081491	Amino Acids	Petit CS	Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases.	The Journal of cell biology	2013	78
24656864	Amino Acids	Han B	Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity.	American journal of human genetics	2014	36
24808134	Amino Acids	Thomson R	Evolution of the primate trypanolytic factor APOL1.	Proceedings of the National Academy of Sciences of the United States of America	2014	55
24980502	Amino Acids	McGough IJ	Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation.	Current biology 	2014	28
25070946	Amino Acids	Okada Y	Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations.	Human molecular genetics	2014	22
25242279	Amino Acids	Huang K	Growing knowledge of the mTOR signaling network.	Seminars in cell & developmental biology	2014	66
25484089	Amino Acids	Shen WC	Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism.	Autophagy	2015	18
25651891	Amino Acids	Bowes J	Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.	Nature communications	2015	29
25691689	Amino Acids	Soininen P	Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics.	Circulation. Cardiovascular genetics	2015	58
25751625	Amino Acids	Michailidou K	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.	Nature genetics	2015	129
25817017	Amino Acids	Carmona FD	A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.	American journal of human genetics	2015	16
25919528	Amino Acids	Viatte S	Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response.	JAMA	2015	21
26212640	Amino Acids	Tan H	Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity.	Scientific reports	2015	17
26311460	Amino Acids	Stinghen AE	Uremic Toxicity of Advanced Glycation End Products in CKD.	Journal of the American Society of Nephrology 	2016	23
26362759	Amino Acids	Rothwell S	Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups.	Annals of the rheumatic diseases	2016	11
26543160	Amino Acids	Ye J	GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2.	Genes & development	2015	34
26553974	Amino Acids	McLaren PJ	Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.	Proceedings of the National Academy of Sciences of the United States of America	2015	20
26587888	Amino Acids	Wibmer AG	Molecular Imaging of Prostate Cancer.	Radiographics 	2016	10
26590448	Amino Acids	Ramezani A	Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.	American journal of kidney diseases 	2016	17
26658722	Amino Acids	Shimobayashi M	Multiple amino acid sensing inputs to mTORC1.	Cell research	2016	35
26724171	Amino Acids	Parks SK	Hypoxia optimises tumour growth by controlling nutrient import and acidic metabolite export.	Molecular aspects of medicine	2016	13
26733412	Amino Acids	Aguirre GA	Insulin-like growth factor-1 deficiency and metabolic syndrome.	Journal of translational medicine	2016	23
26742086	Amino Acids	Carroll B	Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity.	eLife	2016	22
26797105	Amino Acids	Pires DE	In silico functional dissection of saturation mutagenesis: Interpreting the relationship between phenotypes and changes in protein stability, interactions and activity.	Scientific reports	2016	16
26902204	Amino Acids	Hinrich AJ	Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides.	EMBO molecular medicine	2016	13
27043018	Amino Acids	Goldman-Pinkovich A	An Arginine Deprivation Response Pathway Is Induced in Leishmania during Macrophage Invasion.	PLoS pathogens	2016	12
27076075	Amino Acids	Goberdhan DC	Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot.	Cell metabolism	2016	25
27106405	Amino Acids	Albert NL	Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.	Neuro-oncology	2016	24
27109103	Amino Acids	Patil MD	Arginine dependence of tumor cells: targeting a chink in cancer's armor.	Oncogene	2016	11
27247400	Amino Acids	Li H	Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques.	Proceedings of the National Academy of Sciences of the United States of America	2016	26
27409811	Amino Acids	Pedersen HK	Human gut microbes impact host serum metabolome and insulin sensitivity.	Nature	2016	63
27442752	Amino Acids	Garwood CJ	Review: Astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role.	Neuropathology and applied neurobiology	2017	7
27597529	Amino Acids	Wolk A	Potential health hazards of eating red meat.	Journal of internal medicine	2017	7
27617932	Amino Acids	Pan M	Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation.	Nature cell biology	2016	19
27729456	Amino Acids	Strenzke N	Hair cell synaptic dysfunction, auditory fatigue and thermal sensitivity in otoferlin Ile515Thr mutants.	The EMBO journal	2016	10
27816754	Amino Acids	Kim Y	Characterizing the mode of action of extracellular Connexin43 channel blocking mimetic peptides in an in vitro ischemia injury model.	Biochimica et biophysica acta	2017	5
27847359	Amino Acids	Srivastava R	Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.	Journal of virology	2017	5
27852637	Amino Acids	Cui Z	MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy.	Journal of the American Society of Nephrology 	2017	5
27898682	Amino Acids	Lotta LA	Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis.	PLoS medicine	2016	13
27998952	Amino Acids	Hinks A	Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases.	Annals of the rheumatic diseases	2017	6
28089725	Amino Acids	Zhenyukh O	High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation.	Free radical biology & medicine	2017	7
28333144	Amino Acids	Jones VC	Aberrant iPSC-derived human astrocytes in Alzheimer's disease.	Cell death & disease	2017	8
28537546	Amino Acids	Zhu W	Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017.	Euro surveillance 	2017	12
18421051	lapatinib	Lin NU	Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.	Journal of clinical oncology 	2008	101
19228746	lapatinib	Lin NU	Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.	Clinical cancer research 	2009	115
22059152	lapatinib	Guo D	An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.	Cancer discovery	2011	70
23071597	lapatinib	Nowsheen S	Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells.	PloS one	2012	33
26022204	lapatinib	Javle M	HER2/neu-directed therapy for biliary tract cancer.	Journal of hematology & oncology	2015	17
21748296	sorafenib	El-Khoueiry AB	SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.	Investigational new drugs	2012	39
21816126	sorafenib	Sangro B	Radioembolization for hepatocellular carcinoma.	Journal of hepatology	2012	62
22374331	sorafenib	Llovet JM	Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.	Clinical cancer research 	2012	112
25216638	sorafenib	Rudalska R	In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.	Nature medicine	2014	43
28056412	sorafenib	Kroeze SG	Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review.	Cancer treatment reviews	2017	7
15912889	protectin D1	Bazan NG	Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress.	Brain pathology	2005	68
16151530	protectin D1	Lukiw WJ	A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.	The Journal of clinical investigation	2005	177
17670936	protectin D1	Mukherjee PK	Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling.	Proceedings of the National Academy of Sciences of the United States of America	2007	57
18559988	protectin D1	Merched AJ	Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators.	FASEB journal 	2008	122
19018037	protectin D1	Bazan NG	Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease.	Journal of lipid research	2009	53
21246057	protectin D1	Zhao Y	Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models.	PloS one	2011	59
25139562	protectin D1	Serhan CN	Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome.	Biochimica et biophysica acta	2015	58
16740717	panobinostat	Maiso P	The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.	Cancer research	2006	61
16899611	panobinostat	Giles F	A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies.	Clinical cancer research 	2006	99
18628465	panobinostat	Ellis L	Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma.	Clinical cancer research 	2008	79
20442295	panobinostat	Storch K	Three-dimensional cell growth confers radioresistance by chromatin density modification.	Cancer research	2010	43
21436030	panobinostat	Pipalia NH	Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts.	Proceedings of the National Academy of Sciences of the United States of America	2011	60
24435446	panobinostat	Fiskus W	Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.	Molecular cancer therapeutics	2014	43
26640144	panobinostat	Ruscetti M	HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.	Oncogene	2016	12
28076695	panobinostat	Laubach JP	Deacetylase inhibitors: an advance in myeloma therapy?	Expert review of hematology	2017	6
15604286	2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one	Hickson I	Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.	Cancer research	2004	432
17283137	2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one	Golding SE	Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.	Cancer research	2007	63
17431503	2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one	Kennedy RD	Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.	The Journal of clinical investigation	2007	59
17786248	2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one	Eaton JS	Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis.	The Journal of clinical investigation	2007	60
19544417	2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one	Momcilović O	Ionizing radiation induces ataxia telangiectasia mutated-dependent checkpoint signaling and G(2) but not G(1) cell cycle arrest in pluripotent human embryonic stem cells.	Stem cells	2009	56
19808981	2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one	Golding SE	Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.	Molecular cancer therapeutics	2009	90
20615625	2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one	Sanli T	Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells.	International journal of radiation oncology, biology, physics	2010	57
22099611	MDV 3100	Armstrong AJ	Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancer.	European urology	2012	44
22894553	MDV 3100	Scher HI	Increased survival with enzalutamide in prostate cancer after chemotherapy.	The New England journal of medicine	2012	708
24163104	MDV 3100	Svensson C	REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.	Nucleic acids research	2014	24
24759320	MDV 3100	Asangani IA	Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.	Nature	2014	184
25135278	MDV 3100	Hu S	Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling.	Molecular oncology	2015	18
26792867	MDV 3100	Asangani IA	BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer.	Molecular cancer research 	2016	20
25037139	vemurafenib	Ribas A	Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study.	The Lancet. Oncology	2014	36
25278616	vemurafenib	Savitski MM	Tracking cancer drugs in living cells by thermal profiling of the proteome.	Science	2014	57
25520039	vemurafenib	Maverakis E	Metastatic melanoma - a review of current and future treatment options.	Acta dermato-venereologica	2015	19
27188223	vemurafenib	Schadendorf D	Melanoma.	Nature reviews. Disease primers	2015	37
27460442	vemurafenib	Brose MS	Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial.	The Lancet. Oncology	2016	13
24352789	Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))	Afshar-Oromieh A	Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience.	European journal of nuclear medicine and molecular imaging	2014	36
26294298	Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))	Afshar-Oromieh A	The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions.	Journal of nuclear medicine 	2015	35
26404016	Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))	Sterzing F	(68)Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients.	European journal of nuclear medicine and molecular imaging	2016	19
26683282	Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))	van Leeuwen PJ	(68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment.	BJU international	2016	17
27056618	Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))	Rahbar K	Response and Tolerability of a Single Dose of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Analysis.	Journal of nuclear medicine 	2016	19
27660138	Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))	Okamoto S	Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions.	Journal of nuclear medicine 	2017	7
27889802	Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))	Giesel FL	F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients.	European journal of nuclear medicine and molecular imaging	2017	8
28283702	Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))	Fendler WP	68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.	European journal of nuclear medicine and molecular imaging	2017	8
9278512	cholecystokinin C-terminal flanking peptide	Peng CY	Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.	Science	1997	332
9407038	cholecystokinin C-terminal flanking peptide	Siliciano JD	DNA damage induces phosphorylation of the amino terminus of p53.	Genes & development	1997	199
11331603	cholecystokinin C-terminal flanking peptide	Maya R	ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.	Genes & development	2001	175
11333986	cholecystokinin C-terminal flanking peptide	Bulavin DV	Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase.	Nature	2001	128
11780126	cholecystokinin C-terminal flanking peptide	D'Orazi G	Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.	Nature cell biology	2002	180
15800615	cholecystokinin C-terminal flanking peptide	Esashi F	CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair.	Nature	2005	142
15870257	cholecystokinin C-terminal flanking peptide	Lu X	PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints.	Genes & development	2005	124
17101782	cholecystokinin C-terminal flanking peptide	Tan Y	Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes.	Molecular and cellular biology	2007	89
18184780	cholecystokinin C-terminal flanking peptide	Terunuma M	Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus.	The Journal of neuroscience 	2008	57
19091954	cholecystokinin C-terminal flanking peptide	Wilsker D	Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control.	Proceedings of the National Academy of Sciences of the United States of America	2008	55
19357644	cholecystokinin C-terminal flanking peptide	Yun MH	CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle.	Nature	2009	196
19372545	cholecystokinin C-terminal flanking peptide	Park HU	AMP-activated protein kinase promotes human prostate cancer cell growth and survival.	Molecular cancer therapeutics	2009	56
19655382	cholecystokinin C-terminal flanking peptide	Borroni B	Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease.	Human mutation	2009	71
19666107	cholecystokinin C-terminal flanking peptide	Kaspar JW	Nrf2:INrf2 (Keap1) signaling in oxidative stress.	Free radical biology & medicine	2009	272
20023628	cholecystokinin C-terminal flanking peptide	Sibanda BL	Crystal structure of DNA-PKcs reveals a large open-ring cradle comprised of HEAT repeats.	Nature	2010	82
20064390	cholecystokinin C-terminal flanking peptide	Gu X	Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.	Neuron	2009	117
20139984	cholecystokinin C-terminal flanking peptide	Sun S	SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control.	Nature structural & molecular biology	2010	71
20493860	cholecystokinin C-terminal flanking peptide	Yuan J	Focus on histone variant H2AX: to be or not to be.	FEBS letters	2010	64
20919648	cholecystokinin C-terminal flanking peptide	Nikolova-Karakashian MN	Ceramide in stress response.	Advances in experimental medicine and biology	2010	43
22361354	cholecystokinin C-terminal flanking peptide	Khoronenkova SV	ATM-dependent downregulation of USP7/HAUSP by PPM1G activates p53 response to DNA damage.	Molecular cell	2012	45
11134068	AX 115	Schultz LB	p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks.	The Journal of cell biology	2000	266
12077346	AX 115	Mahajan KN	Association of DNA polymerase mu (pol mu) with Ku and ligase IV: role for pol mu in end-joining double-strand break repair.	Molecular and cellular biology	2002	86
12231622	AX 115	Chan DW	Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks.	Genes & development	2002	157
14742437	AX 115	Ward IM	UV-induced ataxia-telangiectasia-mutated and Rad3-related (ATR) activation requires replication stress.	The Journal of biological chemistry	2004	85
14744762	AX 115	Kühne M	A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity.	Cancer research	2004	87
16024812	AX 115	Taipale M	hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells.	Molecular and cellular biology	2005	105
17709392	AX 115	Ikura T	DNA damage-dependent acetylation and ubiquitination of H2AX enhances chromatin dynamics.	Molecular and cellular biology	2007	140
17957241	AX 115	Cowell IG	gammaH2AX foci form preferentially in euchromatin after ionising-radiation.	PloS one	2007	71
18001824	AX 115	Mailand N	RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins.	Cell	2007	452
18158901	AX 115	Xie A	Distinct roles of chromatin-associated proteins MDC1 and 53BP1 in mammalian double-strand break repair.	Molecular cell	2007	105
18344987	AX 115	Tsai WB	Functional interaction between FOXO3a and ATM regulates DNA damage response.	Nature cell biology	2008	54
19252415	AX 115	Golding SE	Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells.	Cancer biology & therapy	2009	57
19373864	AX 115	Filion TM	Survival responses of human embryonic stem cells to DNA damage.	Journal of cellular physiology	2009	56
19377482	AX 115	Lal A	miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells.	Nature structural & molecular biology	2009	103
20016603	AX 115	Galanty Y	Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks.	Nature	2009	207
20081839	AX 115	Noon AT	53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair.	Nature cell biology	2010	123
20139725	AX 115	Löbrich M	gammaH2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization.	Cell cycle	2010	180
20551068	AX 115	Gottipati P	Poly(ADP-ribose) polymerase is hyperactivated in homologous recombination-defective cells.	Cancer research	2010	61
21252160	AX 115	Wang X	Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers.	Clinical cancer research 	2011	42
